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ABSTRACT 
 
Metal-catalyzed cyclopropanation of olefins with diazo reagents has attracted 
research interest because of its fundamental and practical importance. The resulting 
cyclopropyl units are recurrent motifs in biologically important molecules and can serve 
as versatile precursors in organic synthesis. Since they were first introduced in 2004, 
Co(II) complexes of D2-symmetric chiral amidoporphyrins [Co(D2-Por*)] have emerged 
as a new class of catalysts for asymmetric cyclopropanation. These metalloradical 
catalysts have been shown to be highly effective for asymmetric intermolecular 
cyclopropanation of a broad scope of substrates with different classes of carbene sources, 
particularly including electron-deficient olefins and acceptor/acceptor-substituted diazo 
reagents, with excellent diastereoselectivity and enantioselectivity. 
This dissertation focuses on exploring the Co(II)-based metalloradical catalyzed 
enantioselective cyclization reactions. It includes expanding families of catalysts, types of 
reactions and classes of substrates. With the developed novel approach for chiral 
porphyrin ligands, a new family of catalysts bearing different electronic and steric 
characters was synthesized. They turned out to be better catalysts for metalloradical 
cyclization in many cases, for instance, enantioselectivity of intramolecular 
cyclopropanation reached up to 99% with new catalyst. Besides the catalyst synthesis, 
more challenging diazo reagents were successfully employed in both intra- and 
intermolecular cyclopropanation for direct synthesis of highly functionalized 
viii 
 
cyclopropanes. Moreover, a tandem radical cyclization process beyond cyclopropanation 
was discovered, dihydrofuran was generated in a highly selective manner. Last but not 
least, we developed some novel applications of cyclopropane products, which could 
potentially lead to more exciting works. 
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Chapter 1 
Recent Developments of Transition Metal Catalysts for Enantioselective 
Cyclopropanation Reaction  
1.1. Introduction 
The cyclopropane structure, the smallest cycloalkane unit, has attracted great 
attention owing to its unique combination of reactivities and structural properties. It 
resides within a wide range of naturally occurring compounds, including terpenes, 
pheromones, fatty acid metabolites and unusual amino acids.1 The high ring strain and 
unique electronic properties make cyclopropanes extremely valuable synthetic 
intermediates for preparation of other cyclic and acyclic compounds. When they are 
available in enantiopure form, chiral cyclopropanes serve as versatile synthons for 
synthesizing other chiral compounds. Starting from an olefin, three different approaches 
have been developed to build a chiral cyclopropane ring, including i) transition metal-
catalyzed carbene transfer reactions,2 ii) the Simmons-Smith reactions,3 and iii) 
nucleophilic addition-ring closure sequences catalyzed by organocatalysts.4 This chapter 
intends to provide an overview about the most important development of the first 
approach for the past two decades, with emphasis on enantioselective processes.  
1.2.Different Types of Transition Metal Catalysts 
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Cyclopropanation of olefins via carbene transfer catalyzed by transition metal 
complexes represents one of the most attractive approaches to the stereoselective 
preparation of chiral cyclopropane derivatives. Catalysts derived from copper, rhodium, 
and, more recently, ruthenium and cobalt have been developed to achieve high 
stereocontrol and efficacy in constructing the smallest all-carbon ring structure. Catalysts 
based on other late transition metals such as gold,5 iron,6 iridium7 and osmium8 have also 
been reported albeit less commonly. 
1.2.1 Copper-Based Catalysts 
The first example of asymmetric cyclopropanation was reported in 1966 by 
Noyori and coworkers with the use of a copper complex of a chiral salen ligand as the 
catalyst.9 It is worth noting that this also represents the first example of enantioselective 
reaction in a homogenous phase catalyzed by a transition metal. Ligand modification then 
progressed to chiral semicorrin C110 and bisoxazoline ligands L211 (Figure 1.1). For the 
past decades, copper has continued to serve as one of the most attractive metals for 
catalytic cyclopropanation.  
 
 
Figure 1.1. Chiral Copper Semicorrin Complex and Chiral Bisoxazoline Ligand. 
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Among all the chiral ligands developed for copper-catalyzed cyclopropanation 
reactions, bidentate bisoxazoline (Box) ligands are the most widely studied. Several 
families of chiral bisoxazolines have been developed bearing different geometries and 
electronic properties of the bridging atoms. For instance, aza-bisoxazoline L3 (Figure 
1.2), an analogue of bisoxazoline that combines the advantages of easy accessibility of 
Box ligand and the structural flexibility of the aza-semicorrin, was shown to be another 
efficient chiral ligand for Cu-catalyzed cyclopropanation of styrene with methyl 
diazoacetate by Reiser and coworkers;12 the copper complex of pyridine-bisoxazoline 
(Pybox) ligand L4 (Figure 1.2) was reported by Landais and coworkers as the first 
example of desymmetrization of a cyclopentadienylsilane using ethyl diazoacetate 
(EDA);13 along this line, the isbut-box L5 and arylid-box L614 (Figure 1.2) were 
synthesized and applied to Cu-catalyzed cyclopropanation in view of their rigid backbone 
and interesting electronic character although only moderate reactivity and 
stereoselectivity were observed; the cyclopropylidene-bridged box L715 (Figure 1.2), on 
the other hand, proved to be a better ligand for Cu-catalyzed cyclopropanation of styrene 
with EDA as a good yield and excellent stereoselectivity (84:16 dr and >99.9% ee) were 
recorded. The effect of substituents at the 4- and 5-positions of the bisoxazoline ligand 
were also evaluated for asymmetric cyclopropanation by Itagaki and coworkers.16 As an 
example, the Cu-complex of L8 (Figure 1.2) was shown to have high efficiency for the 
cyclopropanation of 2,5-dimethyl-2,4-hexadiene with tert-butyl diazoacetate (tBDA) 
(87:13 dr and 96% ee). 
4 
 
 
Figure 1.2. Different Chiral Bisoxazoline Ligands. 
 
In 2005, Pfaltz and coworkers reported a new class of readily available anionic 
boron-bridged Box ligand, such as L9 (Figure 1.2). When it was applied to the Cu-
catalyzed cyclopropanation of various alkenes with 2,6-di-tert-butyl-4-methylphenyl 
(BHT) diazoacetate, excellent diastereoselectivity and enantioselectivity were obtained 
(up to 99:1 dr and 99.5% ee).17 Trisoxazoline Ligand L10 (Figure 1.2) was reported by 
Dai and coworkers in 2007 for the Cu-mediated reaction of styrene with ethyl 
phenyldiazoacetate. The incorporation of a pendant oxazoline as a side arm on 
bisoxazoline proved to be beneficiary as both the yield and enantioselectivity of the 
reaction were improved significantly (up to 92% yield, >99:1 dr and 92% ee).18 
Ligands other than bisoxazolines have also been investigated. For example, the 
C2-symmetric bipyridine-derived ligand L11 (Figure 1.3) was studied by Wilson and 
coworkers because the 2,2´-bipyridine unit offers the potential for a broad range of 
structural modifications, such as the incorporation of stereogenic centers and elements of 
planar and axial chirality.19 Very high diastereoselectivities and enantioselectivities were 
observed (>95:5 dr and up to 99% ee) when ligand L11 (Figure 1.3) was employed in the 
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asymmetric cyclopropanation reactions of a series of alkenes with diazoesters. The same 
series of reactions were tested by Sacchetti and coworkers using the C1-symmetric 
bispidine ligand L12 (Figure 1.3) and up to 98% ee was observed for the trans-
cyclopropane product.20 Other ligands such as chiral binaphthyldiimine L13,21 amino 
alcohol L1422 and L1523 (Figure 1.3) were also investigated. However, only moderate to 
good stereoselectivities were obtained.  
 
 
Figure 1.3. Other Chiral Chelating Ligands of Copper Catalyst. 
 
1.2.2 Rhodium-Based Catalysts 
Rhodium complexes represent another well-known family of effective catalysts 
for enantioselective cyclopropanation. The dirhodium(II) complexes have already proven 
to be effective catalysts for enantioselective cyclopropanation. In particular, the 
development of dirhodium(II) carboxamidate and carboxylate catalysts has resulted in 
highly stereoselective reactions with α-diazocarbonyl compounds via a variety of reaction 
modes. Rh2(5S-MEPY)4 (C16, Figure 1.4), first reported by Doyle and coworkers in 
1991, offered unique advantages for enantioselective intramolecular cyclopropanation 
with allylic diazoacetates (up to 98% ee)24 and homoallylic diazoacetates 1 (up to 90% ee) 
(eq. 1, Figure 1.4).24b By tuning electronic and steric factors of the carboxamide ligand, 
Rh2(4S-MEOX)4 (C17, Figure 1.4) was synthesized and demonstrated as an outstanding 
catalyst for enantioselective intramolecular cyclopropanation of allylic diazoacetamides 
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(up to 98% ee).24b In the case of intermolecular cyclopropanation, the dirhodium 
complexes of the azetidinone-based ligand Rh2[(S,R)-MenthAZ]4 (C19, Figure 1.4) was 
shown to be effective in catalyzing cyclopropanation of terminal olefins using 
vinyldiazolactone 3 (eq. 2, Figure 1.4).25  
 
 
Figure 1.4. Different Chiral Dirhodium(II) Carboxamidates. 
 
Ligand derived from N-arylsulfonylproline was first reported by McKervey and 
coworkers for cyclopropanation of α-diazoketones.26 Later, one of its derivatives, Rh2(S-
DOSP) (C20, Figure 1.5), was reported by Davies and coworkers for cyclopropanation of 
olefins with vinyldiazomethanes.27 The same group further demonstrated that the catalyst 
C20 was particularly suited for the cyclopropanation reactions with donor/acceptor-
substituted diazoesters. High enantioselectivity was routinely achieved with a range of 
diazo reagents containing aryl or vinyl functionality as the electron-donating group.28 For 
other donor/acceptor-substituted diazo compounds such as diazophosphonates29 and 
trifluorodiazoethanes30, the adamantyl catalyst Rh2(S-PTAD)4 (C21, Figure 1.5) was 
shown to proceed with better results. Müller and coworkers demonstrated that Rh2(S-
nttl)4 (C23, Figure 1.5), an analog of Hashimoto’s phthalimido catalyst Rh2(S-pttl)431 
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(C22, Figure 1.5), catalyzed cyclopropanation of styrene derivatives with 
(silanyloxyvinyl)diazoacetates, affording the corresponding vinyl-substituted 
cyclopropanes with exceptional diastereo- and enantioselectivities.32  
 
 
Figure 1.5. Different Chiral Dirhodium(II) Carboxylates. 
 
Aside from these two major families of dirhodium catalysts, another type of 
dirhodium(II) catalysts with ortho-metalated arylphosphine (PC) ligands such as C24a 
and C24b (Figure 1.5) were reported by Lahuerta and coworkers.33 These ligands, with a 
general formula of Rh2(OOCR)2-(PC)2, contain two ortho-metalated phosphines in a 
head-to-tail (H-T) configuration, along with two polarizable aromatic ligands that could 
offer tunable electronic characteristics. These catalysts were capable of providing high 
yields and good level of enantiocontrol in the cyclopropanation of diazo ketones. 
Rarely reported are the monomeric rhodium complexes in catalyzing asymmetric 
cyclopropanation. As a rare example, Bergman and coworkers reported the monomeric 
rhodium(II)-catalyzed asymmetric cyclopropanation with EDA using bisoxazoline as 
ligand.34 More recently, a new chiral diene ligand for rhodium(I)-catalyzed asymmetric 
cyclopropanation was reported as the first successful catalytic system to solve the 
reactivity and selectivity issue of metal malonate carbene.35  
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1.2.3 Ruthenium-Based Catalysts 
Compared to rhodium, ruthenium is still relatively new in the field of catalytic 
cyclopropanation. Most major breakthroughs have been made in the last decade. The 
attention given to ruthenium arose not only out of curiosity but also from two major 
driving forces. One is that ruthenium currently only costs approximately one tenth the 
price of rhodium. The other is that ruthenium complexes have the potential for greater 
diversity due to the larger number of oxidation states and the richer coordination 
chemistry available to ruthenium than those available to rhodium.  
The chiral Ru(pybox) catalyst C25 (Figure 1.6), first developed by Nishiyama and 
coworkers,36 has become one of  the most efficient catalysts for the cyclopropanation of 
alkenes with diazoacetates, affording corresponding cyclopropanes in high 
diastereoselectivities and excellent enantioselectivities (up to 99% ee). The efficiency of 
this enantioselective transformation has been highlighted by its application to the 
synthesis of homotryptamine-like compound BMS-505130.37 It was also applied to α-
diazomethylphosphonates in the presence of olefins to generate optically-enriched 
cyclopropyl phosphonate derivatives.38 As further derivatization to the pybox ligand,  the 
water soluble catalyst C26 (Figure 1.6) was developed and applied to cyclopropanation in 
protic or biphasic media.39 Ruthium-thiobox catalysts such as C27 (Figure 1.6), bearing 
thiophene as the backbone,  were synthesized and found to perform well in 
cyclopropanation of 1,1-diphenylethene with EDA (85% yield, 99% ee,).40  
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 Figure 1.6. Chiral Ruthenium Bis(oxazoliny)pyridines Complexes. 
 
Ruthenium porphyrin 28 (Figure 1.7), reported by both Berkessel’s group and 
Che’s group, was successfully applied to cyclopropanation.41 The ruthenium porphyrin 
complex is attractive due to the unprecedentedly high catalyst turnovers (up to 1.1*104) 
and the high stereoselectivities for cyclopropanation of styrene derivatives with EDA. 
The same ruthenium porphyrin was utilized by Simonneaux and coworkers for group- 
and atom-transfer reactions toward the synthesis of trifluoromethylphenyl 
cyclopropanes42 and cyclopropylphosphonates.43 
 
 
Figure 1.7. Chiral Ruthenium Porphyrin. 
 
Following the success of catalyzing epoxidation, ruthenium salen was extended to 
cyclopropanation. Katsuki and coworkers reported a high enantio- and cis-selectivitve 
cyclopropanation catalyzed by salen complex C29 (Figure 1.8).44 However, the reaction 
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yields were generally low, even under irradiation conditions.  Later, Nguyen and 
coworkers reported the ruthenium salen complexes containing trans-oriented pyridine 
ligands such as C30 (Figure 1.8). These complexes are very efficient catalysts for the 
asymmetric cyclopropanation of both electron-rich and electron-deficient terminal olefins 
with EDA, affording high yield and predominantly trans- products with exceptionally 
high enantioselectivity.45 As a practical application, trans-cyclopropyl α-amino acid 
derivatives were successfully synthesized.46 To further expand this methodology, 
asymmetric cyclopropanation mediated by a combination of achiral ruthenium(salen) 
catalysts and a catalytic amount of chiral sulfoxide additives were reported.47 
 
 
Figure 1.8. Chiral Ruthenium Salen and Other Schiff-base Complexes. 
 
In 2001, Mezzetti and coworkers reported the five-coordinate ruthenium 
complexes [RuCl(P-NNP)]+ (C31a, Figure 1.8) that contains the diphosphinodimino-
ligand. This is the first ruthenium catalytic systems that gave high cis-selectivity.48 The 
subsequent work reported by the same group investigated the electronic tuning of the 
PNNP ligand49 and coordinating counterion,50  two factors deemed as the pivotal 
requirements for catalyst performance in this particular system.  Another ruthenium 
complex with a biaryldiimine ligand, C32 (Figure 1.8), was also shown by Scott and 
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coworkers to afford excellent diastereoselectivity and enantioselectivity on 
cyclopropanation.51  
1.2.4 Cobalt-Based Catalysts 
Cobalt metal complexes are one of the most attractive metal complexes in 
catalysis due to the cheap source and the unique reactivity. In 1978, chiral (dioxmato) 
Co(II) catalysts derived from camphor were observed to have moderate to high reactivity 
and selectivity for the cyclopropanation of different olefins.52 Since then, more and more 
cobalt complexes have been systematically studied in the following years.  
The Co(II) Salen catalytic system is interesting due not only to its high 
enantioselectivity but also its high cis-selectivity and great chemical yield, which is a 
problem faced by ruthenium (NO) salen. Katsuki and coworkers applied both Co(III) 
salen C33 and Co(II) salen C34 (Figure 1.9) to intermolecular cyclopropanation.53 It is 
noteworthy that while both systems afforded excellent enantioselectivities, the former 
favored a trans-selectivity and the latter favored a cis-selectivity. For intramolecular 
cyclopropanation, the less bulky catalyst C35 (Figure 1.9) was needed to guarantee high 
yield.44b 
 
 
Figure 1.9. Chiral Cobalt Salen Complexes. 
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Zhang and coworkers have demonstrated that the Co(II) porphyrin complexes are 
general and efficient catalysts for diastereo- and enantioselective cyclopropanation 
reactions. An array of Co(II) complexes, C36-41 (Figure 1.10), with D2-symmetric chiral 
porphyrins as ligands, were synthesized and systematically studied in cyclopropanations. 
Olefin substrates are not limited to styrene derivatives. The challenging substrates such as 
electron deficient olefins were successfully cyclopropanated with EDA or tBDA in the 
presence of C36.54 Moreover, the long-standing problem of activating the relative stable 
acceptor/acceptor diazo reagents, including α-nitro-diazoacetates55 and α-cyano-
diazoacetates56, could be accomplished by Co(II) porphyrin system for carbene transfer 
cyclopropanation. Excellent yields and high diastereo- and enantioselectivities were 
routinely obtained for most of the cyclopropanated products, making this novel catalyst 
one of the most general ones for asymmetric cyclopropanation. Detailed mechanistic 
studies revealed the existence of carbene radical which is responsible for the high 
reactivities observed in Co(II) porphyrin catalyzed olefin cyclopropanation system.57  
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Figure 1.10. The Array of Chiral Cobalt(II) Porphyrin Complexes. 
 
1.3. Catalytic Mechanisms 
The mechanism of cyclopropanation via diazo reagent decomposition is thought 
to proceed via carbene formation followed by the interaction of the olefin to produce the 
cyclopropane product. There are three general accepted mechanisms for cyclopropanation 
from transition metal catalyzed carbene transfer reactions: i. concerted asynchronous 
mechanism; ii. coordination mechanism and iii. stepwise radical addition mechanism. 
Due to the different characteristic of different transition metals, their mechanisms are 
dissimilar, and their demands for diazo and olefins in terms of steric and electronic nature 
are disparate, too. 
14 
 
The concerted mechanism (Figure 1.11) involve the formation of a extremely 
reactive metal carbene intermediate I1, formed from association of the diazo compound 
and the catalyst with concomitant extrusion of nitrogen, followed by the attack from 
alkene (I2, Figure 1.11), which occured in a side-on approach. It is worth to reveal that 
the interaction between carbene and alkene happened earlier with one of the carbon 
atoms from the C=C bond, final ring closure to the cyclopropane product occurred late 
but still in a concerted manner. This mechanism was usually applied to copper58, 
rhodium27, 59 and ruthenium60, those carbene complexes are known as Fisher-type carbene 
and are very electrophilic, usually share a higher reactivity with electron rich alkenes. 
The coordination mechanism (Figure 1.11) is a complementary pathway to the concerted 
mechanism and it is still poorly understood61, it implies the simultaneous coordination of 
the carbene and the alkene at the metal center (I3, Figure 1.11), complexes may rearrange 
to metallacyclobutane (I4, Figure 1.11), thus, reductive elimination of the metal fragment 
generated the desired cyclopropanes. 
 
 
Figure 1.11. Concerted and Coordination Mechanism. 
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Stepwise radical addition mechanism (Figure 1.12) was only postulated for cobalt 
carbene complexes, it involve the formation of a metalloradical carbene I5.62 The specie 
is a carbon-centered radical and is best described as a one-electron-reduced Fischer-type 
carbene,57 followed by the radical addition to alkenes, form a new carbene based free 
carbon radical I6, the final step of ring closure generate the desired cyclopropane product. 
The metallocarbene radicals possess an extraordinary different reactivity compare to 
Fischer-type carbenes, it is no longer an electrophilic carbene, thus remarkable reactivity 
was observed, such as the effectiveness in cyclopropanation of electron-deficient 
olefins.54b  
 
 
Figure 1.12. Stepwise Radical Addition Mechanism. 
 
1.4. Summary 
Achievements in asymmetric catalytic metal carbene transformations are 
impressive, but they are by no means exhaustive and there is still much work to be done 
16 
 
in this area including expanding the scope of diazo reagents and alkenes which can be 
effectively converted into cyclopropanes. 
   
17 
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Chapter 2 
Cobalt(II)-Catalyzed Enantioselective Intramolecular Cyclopropanation of Allyl 
Diazoacetates 
2.1. Introduction 
Metal-catalyzed asymmetric olefin cyclopropanation with diazo reagents stands as 
one of the most general approaches for the synthesis of optically active cyclopropane 
derivatives.1 Its intramolecular variant offers a powerful strategy for stereoselective 
construction of complex [n.1.0]bicyclic ring systems directly from linear unsaturated 
diazo precursors.1 The resulting bicyclic molecules have been demonstrated as versatile 
intermediates for syntheses of a wide range of important compounds such as 
pharmaceuticals, peptidomimetics, and natural products.2 
Since the feasibility of intramolecular cyclopropanation was first demonstrated in 
1961,3 significant efforts have been devoted to develop chiral metal catalysts for 
controlling the enantioselectivity of the double cyclization reaction, in parallel with the 
development of intermolecular cyclopropanation.1-2 Results seem to indicate that a chiral 
catalyst that is capable of highly asymmetric intermolecular cyclopropanation may not 
necessarily be effective for enantioselective intramolecular cyclopropanation due to 
additional constraints in the transition state of the unimolecular process. In fact, 
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asymmetric intramolecular cyclopropanation is a significantly less developed process in 
comparison with the enormous advancements in asymmetric intermolecular 
cyclopropanation.1-2  
To date, most achievements in asymmetric intramolecular cyclopropanation are 
made for reactions of unsaturated acceptor-substituted diazo reagents, such as 
diazoacetates and diazoacetamides.4,5,6,7 While there have been several reports on 
asymmetric reactions of donor/acceptor-substituted diazo reagents with partial success,8 
intramolecular cyclopropanation of acceptor/acceptor-substituted diazo reagents with 
high enantioselectivity remains a major challenge and is currently limited to the reactions 
of α-diazo-β-ketone sulfones.9 
Since they were first introduced in 2004,10 cobalt(II) complexes of D2-symmetric 
chiral amidoporphyrins [Co(D2-Por*)] have emerged as a new class of catalysts for 
asymmetric cyclopropanation.11 These metalloradical catalysts have been shown to be 
highly effective for asymmetric intermolecular cyclopropanation of a broad scope of 
substrates with different classes of carbene sources, particularly including electron-
deficient olefins and acceptor/acceptor-substituted diazo reagents, in excellent 
diastereoselectivity and enantioselectivity.12 Increasing evidences support an 
unprecedented reaction mechanism for the Co(II)-catalyzed cyclopropanation that 
involves an unusual Co(III)-carbene radical intermediate undertaking a stepwise radical 
addition-substitution pathway.13 This radical mechanism, which is fundamentally 
different from the electrophilic metallocarbene mechanism shared by the commonly used 
Rh2 and other closed-shell systems, is consistent with the distinct cyclopropanation 
reactivity profile. So far, the Co(II)-based metalloradical cyclopropanation has been only 
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demonstrated for intermolecular reactions. Considering the more demanding steric 
requirement associated with the double cyclization process, it was unclear whether the 
confined chiral cavity in [Co(D2-Por*)] could fit for intramolecular cyclopropanation. 
Since the metalloradical catalysis operates in a step-wise radical mechanism, could it be 
comparable to the concerted catalytic systems for controlling diastereoselectivity, in 
addition to enantioselectivity? To answer these and related questions and, more 
importantly, address the aforesaid challenges in the area, we embarked on a project to 
study asymmetric intramolecular cyclopropanation.  
2.2. Results and Discussion 
2.2.1 Optimization of Catalytic Conditions 
 
 
Figure 2.1. The Array of Cobalt(II) Porphyrin Complexes. 
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The family of D2-symmetric chiral porphyrins (Figure 2.1) were evaluated for 
their ability to catalyze the intramolecular cyclopropanation process with substrate 6a,14 
and produced the desired bicyclic product 7a. Employing [Co(P1)] as catalyst we found 
the intramolecular cyclopropanation process proceeds efficiently with moderate 
enantioselectivity (Table 2.1, entry 1). As seen in previous intermolecular 
cyclopropanation systems, the use of an axial donor ligand, such as DMAP, has a positive 
trans effect and results in an increase in enantioselectivity(Table 2.1, entry 2).15 
 
Table 2.1. Intramolecular Cyclopropanation by Chiral Cobalt(II) Porphyrins.a 
 
a Reaction conditions: Performed at 25 oC for 24 h with MeCN as solvent using 2 mol % 
of catalyst; [substrate] = 0.2 M. b See Figure 1.10. c 0.5 equiv of additive. d Isolated yield. 
e Determined by chiral GC. 
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The results demonstrated significant dependence on the bulky nature of the ligand. 
For example, sterically more encumbered [Co(P2)] catalyzed the reaction with a slightly 
lower yield and enantioselectivity than [Co(P1)] (Table 2.1, entry 3). Catalysts with 
considerably more sterically encumbered ligand designs [Co(P3-P6)] were unable to 
effectively generate the bicyclic product (Table 2.1, entries 4-7). 
 
Table 2.2. Intramolecular Cyclopropanation with [Co(P1)] in Various Solvents.a 
 
a Reaction conditions: Performed at 25 oC for 24 h with 0.5 equiv of DMAP and 2 mol % 
of catalyst; [substrate] = 0.2 M. b Isolated yield. c Determined by chiral GC. 
 
After catalyst screen, several solvents were evaluated for their effect on the 
selectivity and efficiency of the intramolecular cyclopropanation process with [Co(P1)].  
The catalytic system could proceed under a variety of solvent conditions including: 
coordinating solvents (Table 2.2, entries 1-2), a broad range of polarities from highly 
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polar ethyl acetate to non-polar hexanes (Table 2.2, entries 3-4), as well as aromatic and 
chlorinated solvents (Table 2.2, entries 5-8). The disparity in enantioselectivities was 
very minimal over this broad range of solvent characteristics; however the efficiency of 
the reaction diminished when the strongly coordinating solvent THF was used as well as 
the non-polar hexanes which was likely due to poor solubility. Upon achieving these 
results, DCM was selected as the solvent due to these conditions providing the greatest 
enantioselectivity while retaining a moderate to high yield.  
Through these extensive attempts, the ee of 7a is still moderate, there are no 
major improvements compare to the existing catalyst system. It prompted us to develop 
new generation catalysts by exploiting an iterative approach (Figure 2.2) that is based on 
the combination between the modular design of the D2-symmetric chiral porphyrins and 
the high stereoselectivities of [Co(D2-Por*)]-catalyzed intermolecular 
cyclopropanation.10, 16 Starting from optically pure chiral amide 8, which is available 
inexpensively from commercial sources, this iterative approach allows for effective 
generation of diverse cyclopropanecarboxyamides in high enantiomeric purity that can be 
further utilized as chiral building blocks for construction of new generation [H2(D2-
Por*)]. As one of applications of this approach, the metalloradical catalyst [Co(P7)], 
which represents the first example of [Co(D2-Por*)] bearing chiral amides (12, Figure 
2.2) with two contiguous stereocenters, was designed and synthesized from a-
methylstyrene. 
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Figure 2.2. Iterative Approach for Development of New Generation [Co(D2-Por*)] and 
Its Application for Synthesis of [Co(P7)]. 
 
Gratifyingly, [Co(P7)] was found to be a superior chiral catalyst over [Co(P1)] 
for asymmetric intramolecular cyclopropanation of 6a, resulting in the quantitative 
formation of the desired 7a as a single diastereomer with 99% ee (Table 2.3). It is 
fascinating to note that the chirality in [Co(P7)] was originated from [Co(P1)].  
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Table 2.3. Ligand Effect on Asymmetric Intramolecular Cyclopropanation of Cinnamyl-
Diazoacetate by [Co(D2-Por*)]. 
 
 
2.2.2 Substrate Scope and Limitation 
Compare to cinnamyl diazoacetate (6a), allyl diazoacetates with α-acceptor 
substituents such as cyano-, nitro-, keto-, and ester groups (Figure 2.3: X = CN; NO2; 
C(O)R and CO2R, respectively), which are a class of common unsaturated 
acceptor/acceptor-substituted diazo reagents, have not been successfully demonstrated as 
effective substrates for asymmetric intramolecular cyclopropanation. Considering that the 
resultant 3-oxabicyclo[3.1.0]hexan-2-one derivates possess three contiguous chiral 
centers including one multifunctionalized quaternary stereogenic carbon (7, Figure 2.3), 
this family of enantioselective transformations would be highly attractive for synthetic 
applications. 
 31 
 
There have been only a few previous reports on catalytic systems for asymmetric 
cyclopropanation of allyl α-acceptor-substituted diazoacetates (Figure 2.3). While there 
has been no report on allyl α-nitrodiazoacetates (X=NO2),17 the only report on 
asymmetric intramolecular cyclopropanation of allyl α-cyanodiazoacetates (X=CN) 
attained the highest 91% ee in 57% yield with a Rh2-based catalyst.18 The enantiocontrol 
of the catalytic system was shown to be greatly influenced on the substitutes around the 
allyl group, ranging from 29% to 91% ee.18 Whereas the catalytic process for allyl α-
ketodiazoacetates (X=C(O)R) has not been reported,19 prior efforts were made for 
asymmetric intramolecular cyclopropanation of allyl α-esterdiazoacetates (X=CO2R) 
using both Rh2- and Cu-based catalysts, which reached the highest enantioselectivity of 
83% ee but in only 24% yield.20 Once again, the enantioselectivity was found to be 
highly substrate-dependant, ranging from 11% to 83% ee.20 It is evident that asymmetric 
intramolecular cyclopropanation of α-acceptor-substituted diazoacetates is largely an 
unsolved problem and faces formidable challenges in both reactivity and selectivity. 
 
X = NO2: no report
X = CN: 11–85% yield; 29–91% ee (M = Rh2)
X = COR: no report
X = CO2R: 21–81% yield; 11–83% ee (M = Cu and Rh2)
[*LnM] X = CN; NO2;
COR; CO2R
2R O
O
X
N2
2R
O
OXR1 1R
R3 3R6 7
 
Figure 2.3. Enantioselective Intramolecular Cyclopropanation with Allyl α-Acceptor-
Substituted Diazoacetates. 
 
Delightfully, the new metalloradical catalyst [Co(P7)] was shown to be generally 
effective for asymmetric intramolecular cyclopropanation of allyl diazoacetates with 
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different α-substituted groups (Table 2.4). For instance, with no DMAP added, under 
[Co(P7)] catalytic condition, cinnamyl α-cyanodiazoacetate 6b (Table 2.4, entry 2) could 
give the product in 99% yield and 96% ee; cinnamyl α-nitrodiazoacetate (6c) could also 
be effectively catalyzed by [Co(P7)] to give the corresponding cyclopropanation product 
7c in high yield and enantioselectivity (Table 2.4, entry 3). This represents the first 
successful example of asymmetric intramolecular cyclopropanation of allyl α-
nitrodiazoacetates. The absolute configurations of the three contiguous stereogenic 
centers in 7c were established as [1S,5S,6R] by X-ray crystal structural analysis. Under 
the catalysis of [Co(P7)], unsaturated α-ketodiazoacetates could be, for the first time, 
asymmetrically cyclopropanated as exemplified by the successful reaction of cinnamyl α-
ketodiazoacetate (6d). The desired cyclopropanation product 7d was formed with almost 
perfect enantioselectivity, albeit in a lower yield (Table 2.4, entry 4). Considering the 
similarity between keto and ester groups, this high level of enantiomeric control is 
remarkable. The stereocontrol capability of catalyst [Co(P7)] was further demonstrated 
with the highly asymmetric intramolecular cyclopropanation of  cinnamyl α-
esterdiazoacetate (6e) where two ester units differ only by the side groups. In addition to 
high enantioselectivity, the corresponding cyclopropanation product 7e could be obtained 
in almost quantitative yield (Table 2.4, entry 5). Besides acceptor/acceptor-substituted 
diazo substrates, the [Co(P7)]-based system could be also applied for donor/acceptor-
substituted diazo compounds as illustrated with asymmetric intramolecular 
cyclopropanation of α-methyldiazoacetate (6f) (Table 2.4, entry 6). 
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Table 2.4. Asymmetric Intramolecular Cyclopropanation of Allyl Diazoacetates with 
Different α-Substituted Groups by [Co(P7)].a 
 
a Carried out in a one-portion protocol using 2 mol % [Co(P7)] under N2 at RT for 24 h 
in CH2Cl2 with [6] = 0.20 M. b Isolated yields. c Enantiomeric excess of major trans 
diastereomer determined by chiral HPLC. d [1S,5S,6R] Absolute configuration 
determined by anomalous-dispersion effects in X-ray diffraction measurements on single 
crystal. e In the presence of 0.5 eq DMAP. f At 60 ºC. g Determined by chiral GC.  
 
In addition to cinnamyl diazoesters, the [Co(P7)]-based metalloradical catalysis 
could effectively enable asymmetric intramolecular cyclopropanation of other 
unsaturated diazoesters as  demonstrated with a series of allylic α-cyanodiazoacetates 
(Table 2.5). For example, cinnamyl derivatives having alkyl groups substituted at 
different phenyl positions such as 6g, 6h and 6i could be intramolecularly 
cyclopropanated with similarly high yields and stereoselectivities as 6b (Table 2.5, 
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entries 1–4). Besides alkyl substituents, the catalytic system worked equally well with 
derivatives containing electron-withdrawing groups such as Br (Table 2.5, entry 5) and 
CF3 (Table 2.5, entry 6). The Co(II)-catalyzed cyclopropanation could also be 
successfully applied for heteroaryl allylic α-cyanodiazoacetates such as 6l and 6m (Table 
2.5, entries 7 and 8). As well, conjugated allylic α-cyanodiazoacetates as illustrated with 
substrates 6n and 6o could be productively catalyzed to form 3-oxabicyclo[3.1.0]hexan-
2-one derivates 7n and 7o, respectively, although with decreased enantioselectivities 
(Table 2.5, entries 9 and 10). The absolute configurations of the three contiguous 
stereogenic centers in the major enantiomer of 7n were established as [1R,5S,6S] by X-
ray crystal structural analysis. It is worthy of note that two of the three contiguous chiral 
centers in 7o are all-carbon quaternary stereocenters. The catalyst [Co(P7)] was found to 
be similarly active for alkyl-substituted allylic α-cyanodiazoacetates as demonstrated 
with the reaction of 6p, forming the corresponding bicyclic product 7p in excellent yield 
but with moderate enantioselectivity (Table 2.5, entry 11). 
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Table 2.5. [Co(P7)]-Catalyzed Asymmetric Intramolecular Cyclopropanation of Various 
Allyllic a-Cyanodiazoacetates a 
 
a-c See footnotes of Table 2.4. d At 0 ºC. e [1R,5S,6S] Absolute configuration 
determined by anomalous-dispersion effects in X-ray diffraction measurements on single 
crystal. f GC yield. g Determined by chiral GC. h Determined via derivatization. i cis 
isomer. 
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It is noteworthy that all the above catalytic reactions which start from trans- 
alkene, except one (Table 2.5, entry 9), generated the 3-oxabicyclo[3.1.0]hexan-2-one 
products as a single diastereomers. While diastereoselectivity is not an issue for 
intramolecular cyclopropanation by concerted catalytic systems, this fact suggests that 
the last ring-closure step (intramolecular radical substitution) in the stepwise radical 
addition-substitution pathway of Co(II)-catalyzed intramolecular cyclopropanation is a 
low-barrier or barrierless process, the same as shown in Co(II)-catalyzed intermolecular 
cyclopropanation. In the other hand, the catalytic reaction that starts from cis- alkene, two 
diastereomers was observed (Table 2.5, entry 12).  Those interesting phenomenon bring 
us to the detailed mechanism study. 
2.2.3 Proposed Mechanism 
To study the mechanism, the cis-substituted substrate 6r was synthesized and 
applied for this catalytic condition, When 6r is decomposed in the presence of [Co(P7)] 
without DMAP, a mixture of diasteromers are isolated (Figure 2.4).  But with DMAP, 
diazo 6r, functioned as its trans- isomer, only give product 7a, with lower ee. 
 
 
 37 
 
 
Figure 2.4. Stereospecificity of [Co(P7)]-Catalyzed Intramolecular Cyclopropanation. 
 
The possible mechanism21 to explain this difference was displayed below (Figure 
2.5); the interaction of the allylic diazoacetate 6r with the cobalt-complex liberates 
nitrogen gas and generates the cobalt-carbene species. Presumably, when an axial donor 
ligand, such as DMAP, is used, this cobalt carbene species forms the 6-coordinate species 
I9. The resulting carbene-cobalt-DMAP complex is stable enough that the subsequent 
interaction with the olefin allows for the formation of the benzylic radical intermediate 
I10, and through a slow ring closing step is able to produce the sterically less hindered 
product 7a. Conversely, the absence of the axial donor ligand, DMAP, produces a more 
reactive intermediate, the benzylic radical I8, and results in a fast ring closing step and 
generates both products. 
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Figure 2.5. Proposed Mechanism for the Non-stereospecific [Co(P7)]-Catalyzed 
Intramolecular Cyclopropanation. 
 
This phenomenon has also been observed with the Ru-porphyrin intramolecular 
cyclopropanation system of Che-Ming Che and coworkers, who observed a mixture of 
the 7r and 7a diastereomers when 6r was employed in their system.21 Che-Ming Che also 
attributes this observation to a probable step-wise mechanism.  It is worth noting that this 
observation was not made in the Rh2-catalytic intramolecular cyclopropanation system of 
Doyle when the same 6r substrate was utilized.4b 
2.2.4 Further Transformations 
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The demonstrated asymmetric intramolecular cyclopropanation by [Co(P7)]-
based catalytic system paves a practicable way to access optically pure 3-
oxabicyclo[3.1.0]hexan-2-one derivatives bearing multiple stereocenters with dense 
functionalities, which should find a myriad of applications in stereoselective syntheis. As 
the initial exploration of their synthetic applications, we demonstrated that the γ-
butyrolactone unit in the enantioenriched bicyclo[3.1.0]hexane-nitrile 7b could be 
selectively opened with nitrogen-based nucleophiles such as aniline in the presence of 
LDA to produce multi-functionalized cyclopropane derivative 15 as a single diastereomer 
in high yields without loss of the optical purity (Figure 2.6, eq 1). It is noted that 
enantioenriched cyclopropane derivatives like 15 would be difficult or impossible to be 
directly prepared via asymmetric intermolecular cyclopropanation. As another 
demonstration of further stereoselective transformations, the cyclopropane unit in the 
enantioenriched bicyclo[3.1.0]hexane-ester 7e could be enlarged through [3+2] dipolar 
cycloaddition with dipolarophiles such as benzaldehyde to form hexahydrofuro[3,4-
c]furan derivative 16 as a single diastereomer in good yield without change in the optical 
purity under Lewis acid-catalyzed condition (Figure 2.6, eq 2).22 The absolute 
configurations of the four contiguous stereogenic centers in 16 were established as 
[1S,3S,3aS,6aS] by X-ray crystal structural analysis. 
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Figure 2.6. Further transformations of 3-oxabicyclo[3.1.0]hexan-2-one derivatives. 
 
2.3. Experimental Section 
General Considerations. All reactions were carried out under a nitrogen 
atmosphere in oven-dried glassware following standard Schlenk techniques. 
Dichloromethane was distilled under nitrogen from calcium hydride. All cross-coupling 
reactions were carried out under a nitrogen atmosphere in oven-dried glassware following 
standard Schlenk techniques. Tetrahydrofuran (THF) and toluene were distilled under 
nitrogen from sodium benzophenone ketyl. Anhydrous cobalt(II) chloride, palladium(II) 
acetate, and 9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene (Xantphos) were 
purchased from Strem Chemical Co.. Cesium carbonate was obtained as a gift from 
Chemetall Chemical Products, Inc.. Thin layer chromatography was performed on Merck 
TLC plates (silica gel 60 F254). Flash column chromatography was performed with ICN 
silica gel (60 Å, 230-400 mesh, 32-63 μm). Proton and carbon nuclear magnetic 
resonance spectra (1H NMR and 13C NMR) were recorded on a Bruker 250-MHz 
instrument and referenced with respect to internal TMS standard. Infared spectra were 
measured with a Nicolet Avatar 320 spectrometer with a Smart Miracle accessory, HPLC 
measurements were carried out on a Shimadzu HPLC system with Chiralcel OD-H, OJ-H, 
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and AD-H columns. GC measurements were carried out on a Shimadzu GCMS system 
with Chiral GTA and Dex-CB column. HRMS data was obtained on an Agilent 1100 
LC/MS ESI/TOF mass spectrometer with electrospray ionization.  
 
Catalyst Synthesis: 
 
 
(1R,2R)-ethyl 2-methyl-2-phenylcyclopropanecarboxylate (11): 
Co(P1) (1 mol %) and DMAP (40 mol %) were placed in an ovendried, resealable 
Schlenk tube. The tube was capped with a Teflon screwcap, evacuated, and backfilled 
with nitrogen. The screwcap was replaced with a rubber septum, and toluene (8 ml) and 
10 equiv of α-methylstyrene (15 mmol) were added via syringe, after cooled to -60 oC, 
followed by 1.0 equiv of EDA (1.5 mmol) and toluene again (2 ml). The tube was purged 
with nitrogen for 1 min and its contents were stirred at -60 oC for one day, then -40 oC for 
one day, -20 oC for one day and 0 oC for one day. After the reaction finished, the 
resulting mixture was concentrated and the residue was purified by flash silica gel 
chromatography to give the (1R,2R)-ethyl 2-methyl-2-phenylcyclopropanecarboxylate12a 
in 99% yield with only one diastereomer in 97% ee. 1H NMR (250 MHz, CDCl3): δ 7.18-
7.30 (m, 5H), 4.19 (q, J = 7.2 Hz, 2H), 1.96 (dd, J = 8.1, 5.7 Hz, 1H), 1.52 (s, 3H), 1.42 
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(m, 2H), 1.29 (t, J = 7.2 Hz, 3H). 13C NMR (62.5 MHz, CDCl3): δ 172.2, 145.9, 128.4, 
127.3, 126.4, 60.5, 30.5, 27.8, 20.7, 19.8, 14.4. 
 
 
 
(1R, 2R)-2-methyl-2-phenylcyclopropanecarboxamide (12): 
A 250 ml flask was charged with 11 (1.0 mmol), 15 equiv of potassium hydroxide 
(15 mmol, 1.3 g), water (25 ml) and methanol (125 ml). The mixture was stirred at room 
temperature for 12 h. Methanol was removed under rotavape, Conc. HCl (6 ml) in water 
(60 ml) was added slowly under 0oC till the PH value reach 5, and then the mixture was 
extracted three times with dichloromethane (70 ml*3). The collected extracts were 
washed twice with water (50 ml) and dried over magnesium sulfate. Evaporation of the 
solvent afforded the free acid. 
The solution of the free Acid and oxayl chloride (300 mg, 1.95 mmol) in DCM 
(30 ml) was cooled to 0oC, 2-3 drops of DMF was then added. The mixture was stirred 
for 2 h under 0 oC then 5 h under room temperature, remove most of oxayl chloride and 
DCM under rotavape, the residue was then dissolved in 30 ml DCM again and added 
dropwise to the saturate NH3/MeOH solution (10 eq). After reaction finished, the 
resulting mixture was concentrated under rotavape, and the residue was purified by flash 
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silica gel chromatography to afford the (1R, 2R)-2-methyl-2-
phenylcyclopropanecarboxamide with 78% overall yield. The product was recrystallized 
from MeOH/DCM/Hexane to further improve the enantio- purity to 99% ee with only 
one diastereomer. 1H NMR (250 MHz, CDCl3): δ 7.41-6.95 (m, 5H), 6.00-5.32 (m, 2H), 
1.69 (dd, J = 8.32, 5.86 Hz, 1H), 1.46 (s, 3H), 1.41 (dd, J = 5.78, 4.89 Hz, 1H), 1.33 (dd, 
J = 8.31, 4.77 Hz, 1H). 13C NMR (62.5 MHz, CDCl3): δ 173.0, 146.1, 128.5, 126.8, 126.4, 
77.6, 77.1, 76.6, 29.9, 29.5, 19.8, 19.1, HPLC analysis: ee (trans) = 99%. OD-H (80% 
hexanes: 20% isopropanol, 0.8 ml/min) trans-isomer: tmajor = 6.7 min, tminor = 7.4 min. 
 
Table 2.6. Crystal data and structure refinement for compound 12. 
Empirical formula               
Formula weight                  
Temperature                     
Wavelength                      
Crystal system, space group     
Unit cell dimensions            
                                
                                
Volume                          
Z, Calculated density           
Absorption coefficient          
F(000)                          
Crystal size                    
Theta range for data collection 
Limiting indices                
Reflections collected / unique  
Completeness to theta = 66.97   
Absorption correction           
C11 H13 N O 
175.22 
100(2) K 
1.54178 A 
Monoclinic,  P21 
a = 7.5048(2) A   alpha = 90 deg. 
b = 5.1061(2) A    beta = 101.030(2) deg. 
c = 12.4279(4) A   gamma = 90 deg. 
467.44(3) A^3 
2,  1.245 Mg/m^3 
0.631 mm^-1 
188 
0.30 x 0.10 x 0.02 mm 
6.01 to 66.97 deg. 
-8<=h<=8, -4<=k<=5, -14<=l<=14 
5253 / 1415 [R(int) = 0.0187] 
97.6 % 
Semi-empirical from equivalents 
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Table 2.6.continued  
Max. and min. transmission      
Refinement method               
Data / restraints / parameters  
Goodness-of-fit on F^2          
Final R indices [I>2sigma(I)]   
R indices (all data)            
Absolute structure parameter    
Largest diff. peak and hole     
0.9875 and 0.8333 
Full-matrix least-squares on F^2 
1415 / 1 / 119 
1.073 
R1 = 0.0296, wR2 = 0.0757 
R1 = 0.0299, wR2 = 0.0760 
0.0(3) 
0.140 and -0.137 e.A^-3 
 
 
 
 [H2(P7)] were synthesized according to our previous reported procedure,10 with 
80% yield. 1H NMR (250 MHz, CDCl3): δ 8.95 (s, 8H), 8.53 (d, J = 8.0 Hz, 4H), 7.90 (t, 
J = 8.3 Hz, 2H), 7.71 (s, 4H), 7.70 (s, 2H), 6.68 (s, 4H), 6.16-6.10 (m, 4H), 5.44-5.38 (m, 
16H), 1.30 (s, 36H), 1.15 (s, 12H), 1.06 (t, J = 5.3 Hz, 4H), 0.56 (brs, 4H), 0.23 (brs, 4H), 
-2.23 (s, 2H). 13C NMR (62.5 MHz, CDCl3): δ 168.5, 149.1, 144.8, 139.5, 139.1, 133.9, 
130.6, 130.4, 129.8, 127.0, 126.1, 125.2, 123.4, 121.4, 117.1, 117.1,107.8, 34.8, 31.4, 
30.1, 29.7, 19.9, 18.2. HRMS (ESI) ([M+H]+) Calcd. for C104H106N8O4: 1530.8337, 
Found 1531.8363. UV–vis (CH2Cl2), λmax nm (log ε): 424(5.48), 517(4.37), 552(4.01), 
592(3.89), 647(3.76). 
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 [Co(P7)] were synthesized according to our previous reported procedure10 with 
98% yield. HRMS (ESI) ([M+H]+) Calcd. for C104H104CoN8O4: 1587.7512, Found 
1588.7585. UV–vis (CH2Cl2), λmax nm (log ε): 416(5.25), 531(4.32). 
Preparation of TfN3 Solution in Hexane: A solution of sodium azide (10 g, 150 
mmol) and tetrabutylammonium hydrogen sulfate, Bu4NHSO4, (0.56 g, 1.64 mmol) in 
distilled water (30 ml) was cooled to 0 °C. A solution of triflic anhydride (8.46 g, 5.0 ml, 
30 mmol) in hexane (25 ml) was then slowly added, and the resulting clear solution was 
stirred for an additional 1 h at 0 °C. The reaction mixture was then extracted with hexane 
(25 ml), and the organic layer was dried over sodium hydroxide pellets and decanted. The 
hexane solution of triflyl azide was used immediately in the subsequent reaction. 
Alternatively, it could be stored at -15 °C for several weeks without significant 
decomposition. The concentration of the azide was estimated based on the total volume 
of the solution and assuming a quantitative conversion based on the amount of triflic 
anhydride used. 
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cinnamyl 2-diazoacetate (6a): DBU (3.55 mmol) dissolved in THF (5 ml) was added 
dropwise over 20 minutes to a stirred solution of cinnamyl 3-oxobutanoate (2.96 mmol) 
and 4-acetamidobenzenesulfonyl azide (3.55 mmol) in THF (20 ml) at 0oC.  The reaction 
was then allowed to warm to room temperature and stir for 12 h overnight.  A solution of 
LiOH (8.88 mmol) dissolved in 20 ml of water was added and stirred for 6 h. The 
reaction mixture was then extracted with ether, washed with brine and dried over MgSO4.  
The resulting mixture was then concentrated and purified by silica gel flash 
chromatography (Hexanes/EtOAc). 1H NMR (250 MHz, CDCl3): δ 7.34 (m, 5H), 6.69 (d, 
J = 15.90 Hz, 1H), 6.33 (dtd, J = 15.88, 6.38, 1.01 Hz, 1H), 4.86 (d, J = 6.43 Hz, 2H). 13C 
NMR (62.5 MHz, CDCl3): δ 166.6, 136.2, 134.4, 128.7, 128.2, 126.7, 123.2, 65.4, 46.4. 
IR (neat, cm-1): 2109.25, 1686.14, 1389.24, 1352.01, 1239.93, 1174.79, 965.78, 730.14, 
691.70. 
 
 
 
Typical Procedure for the Preparation of the α-Diazo-cyano Acetate:18 
cinnamyl 2-cyano-2-diazoacetate (6b), To a stirred solution of the cinnamyl 2-
cyanoacetate (0.5 g,  2.5 mmol) in acetonitrile (15 ml) under N2 was added the above 
triflyl azide solution (3.75 mmol) in hexane. Pyridine (0.4 ml, 5 mmol) was then added 
dropwise (over ca. 5 min). The reaction mixture was stirred at room temperature 
overnight, Purification of the crude residue by flash chromatography on silica gel 
(hex/ethyl acetate) afforded the pure diazo ester as a yellow solid (350 mg, 62 %):  1H 
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NMR (250 MHz, CDCl3) δ 7.26 (m, 5H), 6.62 (d, J = 15.86 Hz, 1H), 6.19 (td, J = 15.86, 
6.69 Hz, 1H), 4.83 (d, J = 6.69 Hz, 2H). 13C NMR (62.5 MHz, CDCl3) δ 161.2, 136.2, 
135.6, 128.8, 128.6, 126.8, 121.4, 107.3, 100.0, 67.8. IR (neat, cm-1): 2229.00, 2134.55, 
1716.69, 1317.17, 1266.58, 1128.91, 737.13, 692.78. 
 
 
cinnamyl 2-diazo-2-nitroacetate (6c):23 1H NMR (250 MHz, CDCl3): δ 7.45-7.13 (m, 
5H), 6.66 (d, J = 15.84 Hz, 1H), 6.22 (td, J = 15.82, 6.76 Hz, 1H), 4.90 (d, J = 6.76 Hz, 
2H). 13C NMR (62.5 MHz, CDCl3): δ 155.3, 136.6, 135.6, 128.8, 128.7, 126.8, 121.1, 
67.4. IR (neat, cm-1): 2145.88, 1744.00, 1516.34, 1316.30, 1285.58, 1214.57, 1105.08, 
968.57, 741.65. 
 
 
cinnamyl 2-diazo-3-oxobutanoate (6d): DBU (3.55 mmol) dissolved in THF (5 ml) was 
added dropwise over 20 minutes to a stirred solution of cinnamyl 3-oxobutanoate (2.96 
mmol) and 4-acetamidobenzenesulfonyl azide (3.55 mmol) in THF (20 ml) at 0 oC.  The 
reaction was then allowed to warm to room temperature and stir for 12 h overnight. The 
reaction mixture was washed then extracted with diethyl ether; the combined organic 
solution was washed with brine and dried over MgSO4.  The resulting mixture was then 
concentrated and purified by silica gel flash chromatography (Hexanes/EtOAc). 1H NMR 
(250 MHz, CDCl3): δ 7.26 (m, 5H), 6.62 (d, J = 15.86 Hz, 1H), 6.23 (td, J = 15.86, 6.60 
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Hz, 1H), 4.82 (d, J = 6.60 Hz, 2H), 2.42 (s, 3H). 13C NMR (62.5 MHz, CDCl3): δ 190.2, 
161.3, 135.8, 135.4, 128.7, 128.4, 126.8, 122.3, 100.0, 65.9, 28.4. IR (neat, cm-1): 
2139.29, 1714.28, 1655.25, 1364.01, 1312.88, 1248.47, 1151.59, 1061.31, 966.17, 742.50. 
 
 
1-cinnamyl 3-ethyl 2-diazomalonate (6e): DBU (3.55 mmol) dissolved in CH3CN (5 ml) 
was added dropwise over 20 minutes to a stirred solution of cinnamyl ethyl malonate 
(2.96 mmol) and 4-acetamidobenzenesulfonyl azide (3.55 mmol) in CH3CN (20 ml) at 0 
oC.  The reaction was then allowed to warm to room temperature and stir for 12 h 
overnight.  The reaction mixture was then washed and extracted with ether , the 
combined organic solution was washed with brine and dried over MgSO4.  The resulting 
mixture was then concentrated and purified by silica gel flash chromatography 
(Hexanes/EtOAc). 1H NMR (250 MHz, CDCl3): δ 7.40-6.97 (m, 5H), 6.56 (d, J = 15.88 
Hz, 1H), 6.18 (td, J = 15.86, 6.42 Hz, 1H), 4.75 (d, J = 6.41 Hz, 2H), 4.17 (q, J = 7.10 Hz, 
2H), 1.19 (t, J = 7.11 Hz, 3H). 13C NMR (62.5 MHz, CDCl3): δ 160.8, 136.0, 134.9, 
128.6, 128.2, 126.7, 122.5, 65.9, 61.7, 14.4. HRMS (ESI) ([M+Na]+) Calcd. for 
C14H14N2O4: 274.0954, Found 297.0851. IR (neat, cm-1): 2140.44, 1757.97, 1736.70, 
1320.08, 1268.81, 1093.41, 761.68. 
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cinnamyl 2-diazopropanoate (6f):8a 1H NMR (250 MHz, CDCl3): δ 7.38-7.14 (m, 5H), 
6.58 (d, J = 15.83 Hz, 1H), 6.22 (td, J = 15.83, 6.35 Hz, 1H), 4.75 (dd, J = 6.35, 1.27 Hz, 
2H), 1.50 (s, 1H). 13C NMR (62.5 MHz, CDCl3): δ 167.7, 136.2, 134.1, 128.6, 128.1, 
126.7, 123.5, 77.8, 77.3, 76.8, 65.4, 29.8, 8.5. HRMS (ESI) ([M+Na]+) Calcd. for 
C12H12N2O2: 216.0899, Found 239.0801. IR (neat, cm-1): 2082.67, 1687.71, 1327.07, 
1311.40, 1129.83, 967.88, 742.75. 
 
 
(E)-3-(4-tert-butylphenyl)allyl 2-cyano-2-diazoacetate (6g):1H NMR (250 MHz, 
CDCl3): δ  7.24 (s, 4H), 6.57 (d, J = 15.84 Hz, 1H), 6.13 (td, J = 15.82, 6.73 Hz, 1H), 
4.78 (d, J = 6.72 Hz, 2H), 1.21 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ 161.2, 151.8, 
136.0, 132.9, 126.6, 125.7, 120.7, 107.5, 67.9, 34.7, 31.3. HRMS (ESI) ([M+Na]+) Calcd. 
for C16H17N3O2: 283.1321, Found 306.1220. IR (neat, cm-1): 2228.62, 2133.47, 1716.66, 
1317.10, 1265.93, 1132.53, 737.37. 
 
 
(E)-3-p-tolylallyl 2-cyano-2-diazoacetate (6h): 1H NMR (250 MHz, CDCl3): δ 7.26-
7.20 (m, 2H), 7.13-7.03 (m, 2H), 6.61 (d, J = 15.84 Hz, 1H), 6.16 (td, J = 15.84, 6.78 Hz, 
1H), 4.84 (dd, J = 6.78, 1.08 Hz, 1H), 2.28 (s, 1H). 13C NMR (62.5 MHz, CDCl3): δ 
138.6, 136.3, 132.8, 129.4, 126.7, 120.3, 107.3, 67.9, 21.3. HRMS (ESI) ([M+Na]+) 
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Calcd. for C13H11N3O2: 241.0851, Found 264.0749. IR (neat, cm-1): 2228.82, 2136.61, 
1717.01, 1317.02, 1266.34, 1128.93, 736.74. 
 
 
(E)-3-o-tolylallyl 2-cyano-2-diazoacetate (6i): 1H NMR (250 MHz, CDCl3): δ 7.37 (m, 
1H), 7.24-7.02 (m, 3H), 6.87 (d, J = 15.69 Hz, 1H), 6.10 (td, J = 15.69, 6.66 Hz, 1H), 
2.29 (s, 3H). 13C NMR (62.5 MHz, CDCl3): δ 138.6, 136.3, 132.8, 129.4, 126.7, 120.3, 
107.3, 67.9, 21.3. HRMS (ESI) ([M+Na]+) Calcd. for C13H11N3O2: 241.0851, Found 
264.0753. IR (neat, cm-1): 2228.60, 2136.93, 1718.20, 1381.95, 1317.43, 1266.36, 
1135.08, 737.32. 
 
 
(E)-3-(4-bromophenyl)allyl 2-cyano-2-diazoacetate (6j): 1H NMR (250 MHz, CDCl3): 
δ 7.46-7.30 (m, 2H), 7.30-7.11 (m, 2H), 6.57 (d, J = 15.90 Hz, 1H), 6.19 (td, J = 15.87, 
6.57 Hz, 1H), 4.84 (dd, J = 6.57, 0.94 Hz, 2H). 13C NMR (62.5 MHz, CDCl3): δ 161.2, 
134.8, 134.6, 131.9, 128.3, 122.5, 122.2, 107.2, 67.5. IR (neat, cm-1): 2229.00, 2133.56, 
1716.58, 1317.56, 1265.30, 1129.98, 736.56. 
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(E)-3-(4-(trifluoromethyl)phenyl)allyl 2-cyano-2-diazoacetate (6k): 1H NMR (250 
MHz, CDCl3) : δ 7.47 (d, J = 8.28 Hz, 2H), 7.36 (d, J = 8.28 Hz, 2H), 6.60 (d, J = 15.95 
Hz, 1H), 6.25 (td, J = 15.95, 6.35 Hz, 1H), 4.82 (dd, J = 6.35, 0.86 Hz, 2H). 13C NMR 
(62.5 MHz, CDCl3): δ 138.6, 136.3, 132.8, 129.4, 126.7, 120.3, 107.3, 67.9, 21.3. HRMS 
(ESI) ([M+Na]+) Calcd. for C13H8F3N3O2: 295.0569, Found 318.0464. IR (neat, cm-1): 
2230.02, 2137.76, 1719.99, 1615.68, 1324.44, 1267.9, 11123.89, 1067.22. 
 
 
(E)-3-(furan-2-yl)allyl 2-cyano-2-diazoacetate (6l): 1H NMR (250 MHz, CDCl3) : δ 
7.29 (d, J = 1.44 Hz, 1H), 6.42 (d, J = 15.76 Hz, 1H), 6.30 (dd, J = 3.30, 1.83 Hz, 1H), 
6.25 (d, J = 3.27 Hz, 1H), 6.10 (td, J = 15.73, 6.67 Hz, 1H), 4.79 (d, J = 6.63 Hz, 2H). 
13C NMR (62.5 MHz, CDCl3): δ 161.2, 151.4, 142.8, 123.8, 119.8, 111.6, 109.9, 107.4, 
77.7, 77.2, 76.7, 67.2, 53.6. IR (neat, cm-1): 2229.00, 2136.56, 1716.58, 1318.97, 1295.28, 
1261.99, 1128.13, 735.36. 
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(E)-tert-butyl 3-(3-(2-cyano-2-diazoacetoxy)prop-1-enyl)-1H-indole-1-carboxylate 
(6m): 1H NMR (250 MHz, CDCl3): δ 8.11 (d, J = 7.93 Hz, 1H), 7.67 (dd, J = 13.71, 
12.65 Hz, 2H), 7.37-7.13 (m, 3H), 6.76 (d, J = 16.01 Hz, 1H), 6.30 (td, J = 15.90, 6.76 
Hz, 1H), 4.88 (d, J = 6.79 Hz, 2H), 1.61 (s, 9H), 13C NMR  (62.5 MHz, CDCl3): δ161.3, 
161.3, 149.5, 135.9, 128.3, 128.0, 125.3, 124.9, 123.2, 121.4, 119.9, 117.3, 115.5, 107.4, 
84.3, 68.4, 28.2, 22.7. HRMS (ESI) ([M+Na]+) Calcd. for C19H18N4O4: 366.1328, Found 
389.1219. IR (neat, cm-1): 2140.44, 1757.97, 1736.70, 1320.08, 1268.81, 1093.41, 761.68. 
 
 
(2E,4E)-5-phenylpenta-2,4-dienyl 2-cyano-2-diazoacetate (6n): 1H NMR (250 MHz, 
CDCl3) : δ 7.41-7.09 (m, 5H), 6.56 (ddt, J = 25.19, 15.30, 10.12 Hz, 3H), 5.89-5.68 (m, 
1H), 4.77 (d, J = 6.75 Hz, 2H). 13C NMR (62.5 MHz, CDCl3): δ 161.2, 136.6, 136.455, 
135.0, 128.7, 128.2, 127.2, 126.660, 124.9, 107.3, 67.5. HRMS (ESI) ([M+Na]+) Calcd. 
for C14H11N3O2: 253.0851, Found 276.0753. IR (neat, cm-1): 2230.77, 2174.25, 2137.00, 
1702.02, 1319.21, 1298.24, 1215.12, 1138.18, 996.76, 752.01. 
 
 
(2E,4E)-3-methyl-5-phenylpenta-2,4-dienyl 2-cyano-2-diazoacetate (6o): 1H NMR 
(250 MHz, CDCl3): δ 7.24 (m, 5H), 6.65 (dd, J = 40.20, 16.14 Hz, 2H), 5.65 (t, J = 7.35 
Hz, 1H), 4.88 (d, J = 7.35 Hz, 2H), 1.90 (s, 3H). 13C NMR (62.5 MHz, CDCl3): δ 140.3, 
 53 
 
136.9, 131.9, 129.8, 128.7, 127.8, 126.6, 123.5, 63.8, 12.9. IR (neat, cm-1): 2228.98, 
2135.36, 1716.87, 1313.36, 1290.47, 1267.20, 1137.27, 692.86. 
 
 
(E)-pent-2-enyl 2-cyano-2-diazoacetate (6p): 1H NMR (250 MHz, CDCl3): δ 5.82 (td, J 
= 12.76, 6.05 Hz, 2H), 5.64-5.37 (m, 2H), 4.63 (d, J = 6.57 Hz, 2H),  2.13-1.92 (m, 2H), 
0.94 (t, J = 7.44 Hz, 3H), 13C NMR  (62.5 MHz, CDCl3): δ 161.2, 139.9, 121.5, 107.4, 
76.7, 67.9, 25.3, 12.9. IR (neat, cm-1): 2229.52, 2136.48, 1718.46, 1318.97, 1294.54, 
1267.76, 1132.38, 971.63, 738.99. 
 
 
(Z)-pent-2-enyl 2-cyano-2-diazoacetate (6q): 1H NMR (250 MHz, CDCl3): δ 5.64 (td, J 
= 10.78, 7.45 Hz, 1H), 5.43 (ddd, J = 10.86, 9.73, 6.98 Hz, 1H), 4.73 (d, J = 6.97 Hz, 2H), 
2.18-1.97 (m, 2H), 0.92 (t, J = 7.53 Hz, 3H). 13C NMR (62.5 MHz, CDCl3): δ 161.223, 
138.491, 121.309, 107.442, 62.580, 20.877, 13.924. 
 
General Procedure for Cyclopropanation: An oven dried Schlenk tube, that 
was previously evacuated and backfilled with nitrogen gas, was charged with 
diazoacetate (1 eq, if solid), catalyst (2 mol %), and DMAP (if needed).  The Schlenk 
tube was then evacuated and back filled with nitrogen.  The Teflon screw cap was 
replaced with a rubber septum and 0.5 ml portion of solvent was added followed by diazo 
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(1 eq, if liquid), and the remaining solvent (total 0.25 ml).  The Schlenk tube was then 
purged with nitrogen for 1 minute and the rubber septum was replaced with a Teflon 
screw cap.  The Schlenk tube was then placed in an oil bath for the desired time and 
temperature.  Following completion of the reaction, the reaction mixture was purified by 
flash chromatography.  The fractions containing product were collected and concentrated 
by rotary evaporation to afford the compound. In most cases, the product was visualized 
on TLC using the cerium ammonium molybdate (CAM) stain. 
 
 
6-phenyl-3-oxabicyclo[3.1.0]hexan-2-one (7a): [α]20D = -137.49 (c = 0.11, CHCl3). 1H 
NMR (250 MHz, CDCl3): δ 7.32-7.07 (m, 2H), 7.06-6.87 (m, 2H), 4.38 (m, 2H), 2.54-
2.36 (m, 1H), 2.33-2.15 (m, 2H). 13C NMR (62.5 MHz, CDCl3): δ 175.0, 137.2, 128.8, 
127.2, 125.9, 69.8, 29.4, 27.5, 26.2. IR (neat, cm-1): 2244.43, 1771.40, 1663.38, 1252.04, 
1068.24, 995.32, 964.68, 749.66. HPLC analysis: ee (trans) = 99 %. OD-H (80% hexanes: 
20% isopropanol, 0.7 ml/min) trans-isomer: tmajor = 23.1 min, tminor = 21.7 min. 
 
 
2-oxo-6-phenyl-3-oxabicyclo[3.1.0]hexane-1-carbonitrile (7b): [α]20D = 105.77 (c = 
0.10, CHCl3). 1H NMR (250 MHz, CDCl3): δ 7.43-7.08 (m, 5H), 4.53 (dd, J = 9.67, 4.72 
Hz, 1H), 4.36 (d, J = 9.65 Hz, 1H), 3.29 (t, J = 5.06 Hz, 1H), 2.86 (d, J = 5.49 Hz, 1H). 
13C NMR (62.5 MHz, CDCl3): δ 168.2, 130.7, 129.4, 129.2, 127.8, 112.9, 68.4, 36.5, 30.5, 
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26.1. IR (neat, cm-1): 2247.45, 1772.93, 1074.49, 1048.45, 696.39. HPLC analysis: ee 
(trans) = 96%. OD-H (80% hexanes: 20% isopropanol, 0.8 ml/min) trans-isomer: tmajor = 
72.3 min, tminor = 86.6 min. 
 
 
1-nitro-6-phenyl-3-oxabicyclo[3.1.0]hexan-2-one (7c): [α]20D = -26.52 (c = 0.41, 
CHCl3). 1H NMR (250 MHz, CDCl3): δ 7.31-7.17 (m, 5H), 4.58 (dd, J = 9.75, 5.00 Hz, 
1H), 4.29(d, J = 9.75 Hz, 1H), 3.68 (t, J = 5.50 Hz, 1H), 2.92 (d, J = 5.60 Hz, 1H). 13C 
NMR (62.5 MHz, CDCl3): δ163.4, 128.4, 128.0, 127.5, 127.4, 66.1, 38.0, 27.4. HRMS 
(ESI) ([M+Na]+) Calcd. for C11H9NO4: 219.0532, Found 242.0430. IR (neat, cm-1): 
1786.25, 1540.75, 1370.75, 1065.79, 696.78. HPLC analysis: ee (trans) = 88 %. OD-H 
(80% hexanes: 20% isopropanol, 0.8 ml/min) trans-isomer: tmajor = 118.3 min, tminor = 
110.8 min. 
 
Table 2.7. Crystal data and structure refinement for compound 7c. 
Empirical formula                 
Formula weight                    
Temperature                       
Wavelength                        
C11 H9 N O4 
219.19 
100(2) K 
1.54178 A 
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Table 2.7. continued 
Crystal system, space group       
Unit cell dimensions              
                                  
                                  
Volume                            
Z, Calculated density             
Absorption coefficient            
F(000)                            
Crystal size                      
Theta range for data collection   
Limiting indices                  
Reflections collected / unique    
Completeness to theta = 66.65     
Absorption correction             
Max. and min. transmission        
Refinement method                 
Data / restraints / parameters    
Goodness-of-fit on F^2            
Final R indices [I>2sigma(I)]     
R indices (all data)              
Absolute structure parameter      
Extinction coefficient            
Largest diff. peak and hole       
Orthorhombic,  P212121 
a = 6.02060(10) A   alpha = 90 deg. 
b = 15.7711(4) A    beta = 90 deg. 
c = 21.0506(4) A   gamma = 90 deg. 
1998.79(7) A^3 
8,  1.457 Mg/m^3 
0.954 mm^-1 
912 
0.40 x 0.20 x 0.05 mm 
3.50 to 66.65 deg. 
-5<=h<=6, -18<=k<=18, -24<=l<=24 
16161 / 3418 [R(int) = 0.0431] 
96.8 % 
Semi-empirical from equivalents 
0.9538 and 0.7015 
Full-matrix least-squares on F^2 
3418 / 0 / 290 
1.084 
R1 = 0.0379, wR2 = 0.0914 
R1 = 0.0407, wR2 = 0.0931 
0.1(2) 
0.0010(2) 
0.441 and -0.352 e.A^-3 
 
 
6-acetyl-6-phenyl-3-oxabicyclo[3.1.0]hexan-2-one (7d): [α]20D = 85.89 (c = 0.06, 
CHCl3). 1H NMR (250 MHz, CDCl3): δ 7.17 (m 5H), 4.39 (dd, J = 9.43, 4.63 Hz, 1H), 
4.30 (d, J = 9.35 Hz, 1H),3.32 (dd, J = 5.45, 4.88 Hz, 1H), 2.94 (d, J = 5.61 Hz, 1H), 2.29 
(s, 3H). 13C NMR (62.5 MHz, CDCl3): δ 196.9, 171.9, 131.0, 128.7, 128.6, 128.4, 67.5, 
45.5, 40.7, 29.7, 27.0. IR (neat, cm-1): 1764.39, 1700.45, 1374.32, 1258.98, 1096.96, 
1058.62, 767.47, 697.73. HPLC analysis: ee (trans) = 99 %. OD-H (80% hexanes: 20% 
isopropanol, 0.8 ml/min) trans-isomer: tmajor = 42.2 min, tminor = 52.0 min. 
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ethyl 2-oxo-6-phenyl-3-oxabicyclo[3.1.0]hexane-1-carboxylate (7e): [α]20D = 54.93 (c 
= 0.6, CHCl3). 1H NMR (250 MHz, CDCl3): δ 7.32-7.11 (m, 5H), 4.44 (dd, J = 9.37, 4.78 
Hz, 1H), 4.30 (d, J = 9.37 Hz, 1H), 3.88 (m, 2H), 3.23 (t, J = 5.17 Hz, 1H), 2.84 (d, J = 
5.51 Hz, 1H), 0.85 (dt, J = 7.10, 0.74 Hz, 3H). 13C NMR (62.5 MHz, CDCl3): δ 170.1, 
163.5, 131.8, 128.7, 128.5, 128.2, 67.3, 61.8, 37.8, 37.4, 27.4, 13.8. HRMS (ESI) 
([M+H]+) Calcd. for C14H14O4: 246.0892, Found 247.0976. IR (neat, cm-1): 1779.51, 
1731.12, 1453.04, 1373.41, 1256.39, 1153.14, 747.07. HPLC analysis: ee (trans) = 92 %. 
OD-H (60% hexanes: 40% isopropanol, 0.5 ml/min) trans-isomer: tmajor = 23.2 min, tminor 
= 32.1 min.  
 
 
6-methyl-6-phenyl-3-oxabicyclo[3.1.0]hexan-2-one (7f): [α]20D = 24.946 (c = 0.14, 
CHCl3). 1H NMR (250 MHz, CDCl3): δ 7.20 (m, 5H), 4.37 (dd, J = 9.16, 4.61 Hz, 1H), 
4.27 (d, J = 9.10 Hz, 1H), 2.47 (t, J = 4.41 Hz, 1H), 2.31 (d, J = 4.30 Hz, 1H), 1.07 (s, 
3H). 13C NMR (62.5 MHz, CDCl3): δ 178.4, 134.0, 128.6, 127.4, 77.6, 77.1, 76.6, 68.5, 
33.1, 30.3, 26.6, 9.5. HRMS (ESI) ([M+H]+) Calcd. for C12H12O2: 188.0837, Found 
189.0910. IR (neat, cm-1): 1759.61, 1373.81, 1261.21, 1102.14, 1009.88, 767.59, 700.41. 
GC analysis: ee (trans) = 73 %.  Chiral GTA (Temp program: initial temp = 50° C, hold 
time=5 min, Rate: 5.00° C/min, max temp =170° C, hold time= 5 min;) trans-isomer: 
tminor = 30.83 min, tmajor = 31.08 min. 
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6-(4-tert-butylphenyl)-2-oxo-3-oxabicyclo[3.1.0]hexane-1-carbonitrile (7g): [α]20D = 
112.92 (c = 0.10, CHCl3).  1H NMR (250 MHz, CDCl3): δ 7.36 (d, J = 8.44 Hz, 2H), 7.11 
(d, J = 8.44 Hz, 2H), 4.53 (dd, J = 9.65, 4.74 Hz, 1H), 4.36 (d, J = 9.65 Hz, 1H), 3.25 (t, J 
= 5.03 Hz, 1H), 2.83 (d, J = 5.51 Hz, 1H), 1.25 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ 
168.1, 152.4, 127.5, 127.494, 126.1, 113.0, 68.3, 36.3, 34.8, 31.2, 30.6, 25.9. HRMS (ESI) 
([M+H]+) Calcd. for C16H17NO2: 255.1259, Found 256.1338. IR (neat, cm-1): 2247.19, 
1775.85, 1374.97, 1251.83, 1105.01, 1071.87, 1008.60. HPLC analysis: ee (trans) = 96%. 
OD-H (80% hexanes: 20% isopropanol, 0.8 ml/min) trans-isomer: tmajor = 29.0 min, tminor 
= 24.3 min.  
 
O
ONC
 
2-oxo-6-p-tolyl-3-oxabicyclo[3.1.0]hexane-1-carbonitrile (7h): [α]20D = 113.94 (c = 
0.10, CHCl3). 1H NMR (250 MHz, CDCl3): δ 7.23-6.99 (m, 5H), 4.53 (dd, J = 9.66, 4.76 
Hz, 1H), 4.36 (d, J = 9.65 Hz, 1H), 3.26 (t, J = 4.90 Hz, 1H), 2.84 (d, J = 5.52 Hz, 1H), 
2.29 (s, 3H). 13C NMR (62.5 MHz, CDCl3): δ 168.1, 139.2, 129.8, 127.7, 127.5, 112.9, 
68.3, 36.4, 30.4, 26.0, 21.2. HRMS (ESI) ([M+H]+) Calcd. for C13H11NO2: 213.0790, 
Found 214.0864. IR (neat, cm-1): 2246.87, 1773.14, 1374.93, 1252.84, 1105.36, 1072.09, 
1009.18. HPLC analysis: ee (trans) = 98%. OD-H (80% hexanes: 20% isopropanol, 0.8 
ml/min) trans-isomer: tmajor = 40.7 min, tminor = 61.7 min.  
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2-oxo-6-o-tolyl-3-oxabicyclo[3.1.0]hexane-1-carbonitrile (7i): [α]20D = -56.52 (c = 0.16, 
CHCl3). 1H NMR (250 MHz, CDCl3): δ 7.30-6.95 (m, 5H), 4.57 (dd, J = 9.66, 4.82 Hz, 
1H), 4.38 (d, J = 9.64 Hz, 1H), 3.37 (t, J = 5.14 Hz, 1H), 2.84 (d, J = 5.63 Hz, 1H), 2.38 
(s, 3H). 13C NMR (62.5 MHz, CDCl3): δ 168.2, 138.7, 131.1, 129.5, 129.0, 126.8, 126.5, 
112.7, 68.3, 35.3, 29.7, 25.4, 19.5. HRMS (ESI) ([M+H]+) Calcd. for C13H11NO2: 
213.0790, Found 214.0869.  IR (neat, cm-1): 2247.19, 1777.48, 1105.09, 1007.12, 961.20, 
767.34, 735.64. .HPLC analysis: ee (trans) = 96%. OD-H (80% hexanes: 20% 
isopropanol, 0.8 ml/min) trans-isomer: tmajor = 67.0 min, tminor = 91.7 min.  
 
 
6-(4-bromophenyl)-2-oxo-3-oxabicyclo[3.1.0]hexane-1-carbonitrile (7j): [α]20D = 
99.020 (c = 0.14, CHCl3). 1H NMR (250 MHz, CDCl3): δ 7.56-7.41 (m, 1H), 7.07 (m, 
2H), 4.55 (dd, J = 9.74, 4.75 Hz, 1H), 4.38 (d, J = 9.74 Hz, 1H), 3.26 (t, J = 4.75 Hz, 1H), 
2.82 (d, J = 5.46 Hz, 1H). 13C NMR (62.5 MHz, CDCl3): δ 167.2, 131.9, 129.2, 129.0, 
123.0, 112.2, 67.7, 35.2, 30.0, 25.5. IR (neat, cm-1): 2248.43, 1774.98, 1492.65, 1374.83, 
1252.01, 1104.51, 1073.22, 1008.97. HRMS (ESI) ([M+Na]+) Calcd. for C12H8BrNO2: 
276.9738, Found 299.9631. HPLC analysis: ee (trans) = 94%. OD-H (80% hexanes: 20% 
isopropanol, 0.8 ml/min) trans-isomer: tmajor = 38.7 min, tminor = 56.4 min. 
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2-oxo-6-(4-(trifluoromethyl)phenyl)-3-oxabicyclo[3.1.0]hexane-1-carbonitrile (7k): 
[α]20D = 76.64 (c = 0.16, CHCl3). 1H NMR (250 MHz, CDCl3): δ 7.62 (d, J = 8.21 Hz, 
2H), 7.33 (d, J = 8.24 Hz, 2H), 4.58 (dd, J = 9.80, 4.73 Hz, 1H), 4.41 (d, J = 9.70 Hz, 1H), 
3.33 (t, J = 5.06 Hz, 1H), 2.91 (d, J = 5.43 Hz, 1H). 13C NMR (62.5 MHz, CDCl3): δ 
167.5, 134.7, 132.2, 131.6, 131.1, 130.6, 128.3, 126.3, 126.2, 126.1, 126.1, 121.5, 112.4, 
68.2, 35.5, 30.6, 26.1. HRMS (ESI) ([M+Na]+) Calcd. for C13H8F3NO2: 267.0507, Found 
290.0399. IR (neat, cm-1): 2249.42, 1782.59, 1327.56, 1116.75, 1069.50, 1009.57. HPLC 
analysis: ee (trans) = 94%. OD-H (80% hexanes: 20% isopropanol, 0.7 ml/min) trans-
isomer: tmajor = 34.9 min, tminor = 49.9 min. 
 
O
ONC
O  
6-(furan-2-yl)-2-oxo-3-oxabicyclo[3.1.0]hexane-1-carbonitrile (7l): [α]20D = 199.15 (c 
= 0.17, CHCl3).  1H NMR (250 MHz, CDCl3): δ 7.36 (s, 1H), 6.36 (td, J = 3.23, 2.64 Hz, 
2H), 4.53 (dd, J = 9.83, 4.64 Hz, 1H), 4.36 (d, J = 9.76 Hz, 1H), 3.39 (t, J = 4.91 Hz, 1H), 
2.92 (d, J = 5.25 Hz, 1H). 13C NMR (62.5 MHz, CDCl3): δ 167.3, 144.4, 143.8, 112.6, 
111.3, 110.6, 67.9, 30.0, 29.8, 25.0. HRMS (ESI) ([M+H]+) Calcd. for C10H7NO3: 
189.0426, Found 190.0498. IR (neat, cm-1): 2250.57, 1778.20, 1101.18, 1072.26, 1002.58, 
961.67, 737.01. HPLC analysis: ee (trans) = 92%. OD-H (80% hexanes: 20% 
isopropanol, 0.7 ml/min) trans-isomer: tmajor = 42.7 min, tminor = 78.6 min.  
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tert-butyl 3-(1-cyano-2-oxo-3-oxabicyclo[3.1.0]hexan-6-yl)-1H-indole-1-carboxylate 
(7m): [α]20D = 5.35 (c = 0.17, CHCl3). 1H NMR (250 MHz, CDCl3): δ 8.06 (d, J = 7.69 
Hz, 1H), 7.61-7.39 (m, 2H), 7.39-7.07 (m, 2H), 4.55 (dd, J = 9.71, 4.66 Hz, 1H), 4.42 (d, 
J = 9.71 Hz, 1H), 3.28 (t, J = 4.86 Hz, 1H), 2.92 (d, J = 5.29 Hz, 1H), 1.61 (s, 9H). 13C 
NMR (62.5 MHz, CDCl3): δ 167.9, 149.2, 135.4, 129.1, 125.6, 124.3, 123.4, 118.5, 115.7, 
113.0, 111.6, 84.8, 68.2, 30.3, 28.4, 28.2, 25.5. HRMS (ESI) ([M+H]+) Calcd. for 
C19H18N2O4: 338.1267, Found 339.1338. IR (neat, cm-1): 1779.51, 1731.12, 1453.04, 
1373.41, 1256.39, 1153.14,747.07. HPLC analysis: ee (trans) = 92 %. OD-H (60% 
hexanes: 40% isopropanol, 0.5 ml/min) trans-isomer: tmajor = 16.2 min, tminor = 21.4 min.  
 
 
(E)-2-oxo-6-styryl-3-oxabicyclo[3.1.0]hexane-1-carbonitrile (7n): [α]20D = 32.22 (c = 
0.34, CHCl3). 1H NMR (250 MHz, CDCl3): δ 7.64-7.09 (m, 5H), 6.79 (d, J = 15.73 Hz, 
1H), 5.84 (dd, J = 15.71, 8.75 Hz, 1H), 4.52 (dd, J = 9.70, 4.69 Hz, 1H), 4.36 (d, J = 9.69 
Hz, 1H), 3.02 (t, J = 4.76 Hz, 1H), 2.57 (dd, J = 8.65, 5.13 Hz, 1H). 13C NMR (62.5 MHz, 
CDCl3): δ 167.8, 139.6, 137.0, 135.2, 128.7, 126.5, 119.8, 113.2, 68.0, 35.6, 31.7, 24.1. 
HRMS (ESI) ([M+H]+) Calcd. for C14H11NO2: 225.0790, Found 226.0867. IR (neat, cm-
1): 2246.09, 1775.97, 1374.81, 1099.83, 1019.70, 961.55, 751.46. HPLC analysis: 
d.r.=11(cis):89(trans), OD-H (80% hexanes: 20% isopropanol, 0.7 ml/min), ee (cis)= 
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54%. cis-isomer: tmajor = 42.3 min, tminor = 36.0min. ee (trans) = 78%, trans-isomer: tmajor 
= 60.8 min, tminor = 48.3 min. 
 
Table 2.8. Crystal data and structure refinement for compound 7n. 
Empirical formula               
Formula weight                  
Temperature                     
Wavelength                      
Crystal system, space group     
Unit cell dimensions            
                                
                                
Volume                          
Z, Calculated density           
Absorption coefficient          
F(000)                          
Crystal size                    
Theta range for data collection 
Limiting indices                
Reflections collected / unique  
Completeness to theta = 66.20   
Absorption correction           
Max. and min. transmission      
Refinement method               
Data / restraints / parameters  
Goodness-of-fit on F^2          
Final R indices [I>2sigma(I)]   
R indices (all data)            
Absolute structure parameter    
Largest diff. peak and hole     
C14 H11 N O2 
225.24 
100(2) K 
1.54178 A 
Orthorhombic,  P212121 
a = 5.8667(2) A   alpha = 90 deg. 
b = 8.8242(2) A    beta = 90 deg. 
c = 21.4253(5) A   gamma = 90 deg. 
1109.17(5) A^3 
4,  1.349 Mg/m^3 
0.738 mm^-1 
472 
0.20 x 0.03 x 0.02 mm 
4.13 to 67.56 deg. 
-6<=h<=6, -10<=k<=10, -24<=l<=24 
9561 / 1972 [R(int) = 0.0277] 
99.1 % 
Semi-empirical from equivalents 
0.9854 and 0.8664 
Full-matrix least-squares on F^2 
1972 / 0 / 154 
1.026 
R1 = 0.0328, wR2 = 0.0886 
R1 = 0.0336, wR2 = 0.0892 
-0.2(3) 
0.199 and -0.153 e.A^-3 
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(E)-6-methyl-2-oxo-6-styryl-3-oxabicyclo[3.1.0]hexane-1-carbonitrile (7o): [α]20D = 
78.15 (c = 0.05, CHCl3). 1H NMR (250 MHz, CDCl3): δ 7.39-7.13 (m, 5H), 6.65 (d, J = 
15.94 Hz, 1H), 5.91 (dd, J = 15.89, 1.27 Hz, 1H), 4.57 (ddd, J = 10.41, 5.46, 1.39 Hz, 
1H), 4.24 (d, J = 10.40 Hz, 1H), 3.01 (d, J = 5.53 Hz, 1H), 1.48 (d, J = 1.53 Hz, 3H). 13C 
NMR (62.5 MHz, CDCl3): δ 167.8, 139.6, 137.0, 135.2, 128.7, 126.5, 119.8, 113.2, 68.0, 
35.6, 31.7, 24.1. HRMS (ESI) ([M+Na]+) Calcd. for C15H13NO2: 239.0946, Found 
262.0848. IR (neat, cm-1): 2246.09, 1775.97, 1374.81, 1099.83, 1019.70, 961.55, 751.46. 
HPLC analysis: ee (trans) = 84 %. OD-H (80% hexanes: 20% isopropanol, 0.8 ml/min) 
trans-isomer: tmajor = 25.6 min, tminor = 36.3 min.  
 
 
6-ethyl-2-oxo-3-oxabicyclo[3.1.0]hexane-1-carbonitrile (7p): [α]20D = 59.93 (c = 0.11, 
CHCl3). 1H NMR (250 MHz, CDCl3): δ 4.38 (dd, J = 9.61, 4.74 Hz, 1H), 4.20 (dd, J = 
9.61, 0.64 Hz, 1H), 2.62 (t, J = 4.37 Hz, 1H), 1.62 (m, 2H), 1.11 (t, J = 7.24 Hz, 3H). 13C 
NMR (62.5 MHz, CDCl3): δ 168.4, 113.5, 68.0, 34.3, 31.7, 22.6, 22.5, 12.3. HRMS (ESI) 
([M+Na]+) Calcd. for C8H9NO2: 151.0633, Found 174.0532.  GC analysis: ee (trans) = 
78 %. CP-Chirasil-Dex CB (Temp program: initial temp = 50° C, hold time = 5 min, Rate: 
5.00° C/min, max temp =200° C, hold time= 5 min) trans-isomer: tminor = 27.75 min, tmajor 
= 28.14 min. 
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(1R,5S,6R)-6-ethyl-2-oxo-3-oxabicyclo[3.1.0]hexane-1-carbonitrile (7q):18 1H NMR 
(250 MHz, CDCl3): δ 4.47 (ddd, J = 10.21, 5.36, 1.42 Hz, 1H), 4.11 (d, J = 10.23 Hz, 1H), 
3.04-2.87 (m, 1H), 2.03 (dd, J = 15.43, 7.87 Hz, 1H), 1.44 (ddd, J = 14.76, 7.43, 3.88 Hz, 
2H), 1.13-1.01 (t,  J = 7.24 Hz 3H). 13C NMR (62.5 MHz, CDCl3): δ 167.344, 115.869, 
64.890, 33.916, 31.360, 22.798, 16.404, 12.753.  
 
Ph
O
O
CN
+
NH2
Ph
NC
OH
OPhHN
LDA
15: >99:1 d.r.
94 % ee
7b: 94% e.e.
H
THF, -78 oC
92% yield
 
 
 (1R,2S,3R)-1-cyano-2-(hydroxymethyl)-N,3-diphenylcyclopropanecarboxamide (15): 
to a solution of aniline (14 mg, 0.15 mmol) in 5 ml dry THF in -78oC was added LDA(90 
µl, 2.0 M solution in heptanes/tetrahydrofuran/ethylbenzene, 0.18 mmol), the mixture 
was stirred for an hour and was added dropwise to the solution of 7b (19 mg, 0.10 mmol) 
in 10 ml dry THF under  -78oC. The temperature was raised to 0oC and the mixture was 
stirred overnight and concentrated to remove THF, followed by purification of the 
residue by column chromatography, 27 mg (92%) of 1-cyano-2-(hydroxymethyl)-N,3-
diphenylcyclopropanecarboxamide was isolated as solo diastereomer. [α]20D = 146.36 (c 
= 1.1, CHCl3). 1H NMR (250 MHz, CDCl3): δ 8.19 (s, 1H), 7.48-7.05 (m, 10H), 4.08 (dd, 
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J = 12.40, 4.13 Hz, 1H), 3.92 (dd, J = 12.40, 8.08 Hz, 1H), 3.47 (d, J = 8.70 Hz, 1H), 
2.82-2.70 (br, 1H), 2.64 (dt, J = 8.23, 4.17 Hz, 1H). 13C NMR (62.5 MHz, CDCl3): δ 
162.4, 136.7, 133.2, 129.2, 128.9, 128.6, 128.3, 125.7, 120.8, 117.9, 58.3, 38.5, 36.5, 28.7. 
HRMS (ESI) ([M+H]+) Calcd. for C18H16N2O2: 292.1212, Found 293.1271. IR (neat, cm-
1): 3294.17, 2234.50, 1681.46, 1599.65, 1536.13, 1442.96, 751.27, 691.85. HPLC 
analysis: ee (trans) = 94 %. OD-H (80% hexanes: 20% isopropanol, 0.7 ml/min) trans-
isomer: tmajor = 15.3 min, tminor = 44.0 min.  
 
 
(1R,3S)-1-cyano-2-ethyl-3-(hydroxymethyl)-N-phenylcyclopropanecarboxamide 
(7qa): 1H NMR (250 MHz, CDCl3): trans-: δ 8.070 (br, 1H), 7.11-7.44 (m, 5H), 3.90-
4.10(m, 1H), 3.81 (d, J = 7.79 Hz, 1H), 1.85-2.35 (m, 2H), 1.4-1.8 (m, br, 3H), 1.07 (t, J = 
7.38 Hz, 3H). cis-: δ 8.183 (br, 1H), 7.11-7.44 (m, 5H), 3.90-4.10(m, 1H), 3.76 (d, J = 7.76 
Hz, 1H), 2.50(br, 1H), 1.85-2.35 (m, 2H), 1.4-1.8 (m, 2H), 0.97 (t, J = 7.36 Hz, 3H). 13C 
NMR (62.5 MHz, CDCl3): mixture of cis- and trans- δ163.2, 161.8, 136.7, 129.2, 125.5, 
120.6, 118.6, 58.3, 56.9, 41.6, 36.9, 35.4, 34.1, 25.3, 23.9, 21.7, 16.7, 13.4, 12.8.  HRMS 
(ESI) ([M+H]+) Calcd. for C14H16N2O2: 244.1212, Found 245.1285.  HPLC analysis: ee 
(trans) = 69 %. Whelk (90% hexanes: 10% isopropanol, 0.8 ml/min) trans-isomer: tmajor 
= 16.6 min, tminor = 18.8 min; ee (cis) = 23 %. Whelk (90% hexanes: 10% isopropanol, 
0.8 ml/min) cis-isomer: tmajor = 35.6 min, tminor = 29.6 min. 
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 (1S,3R,3aS,6aS)-ethyl 4-oxo-1,3-diphenylhexahydrofuro[3,4-c]furan-3a-carboxylate 
(16): Sc(OTf)3 (0.05 mmol) was placed in an oven-dried, resealable Schlenk tube. The 
tube was capped with a Teflon screwcap, evacuated, and backfilled with nitrogen. The 
screwcap was replaced with a rubber septum. Benzaldehyde (29 mg, 0.3 mmol), 7e (26 
mg, 0.1 mmol) in 1.0 ml DCM was added once via syringe. Schlenk tube was capped by 
teflon screwcap instead of rubber septum and stirred at room temperature for overnight. 
After the reaction finished, the resulting mixture was concentrated to remove DCM, 
followed by purification of the residue by column chromatography, 32 mg (74%) of ethyl 
4-oxo-1,3-diphenylhexahydrofuro[3,4-c]furan-3a-carboxylate was isolated as solo 
diastereomer. [α]20D = -40.47 (c = 0.7, CHCl3). 1H NMR (400 MHz, CDCl3): 7.36-7.07 
(m, 10H), 5.59 (s, 1H), 5.15 (d, J = 4.78 Hz, 1H), 4.19-4.15 (m, 2H), 3.80 (t, J = 9.12 Hz, 
1H), 3.79-3.71 (m, 2H). 13C NMR (62.5 MHz, CDCl3): δ 171.0, 168.2, 135.7, 135.4, 
128.6, 128.5, 128.2, 127.9, 126.3, 125.4, 84.9, 80.9, 66.4, 66.2, 62.7, 51.0, 13.9. HRMS 
(ESI) ([M+Na]+) Calcd. for C21H20O5: 352.1311, Found 375.1200. IR (neat, cm-1): 
1772.21, 1741.84, 1381.44, 1262.63, 1173.71, 1031.01, 1016.63, 695.47, 723.77. HPLC 
analysis: ee (trans) = 90 %. Whelk (90% hexanes: 10% isopropanol, 1.0 ml/min) trans-
isomer: tmajor = 20.7 min, tminor = 23.4 min. 
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Table 2.9. Crystal data and structure refinement for compound 16 
Empirical formula               
Formula weight                  
Temperature                     
Wavelength                      
Crystal system, space group     
Unit cell dimensions            
                                
                                
Volume                          
Z, Calculated density           
Absorption coefficient          
F(000)                          
Crystal size                    
Theta range for data collection 
Limiting indices                
Reflections collected / unique  
Completeness to theta = 66.20   
Absorption correction           
Max. and min. transmission      
Refinement method               
Data / restraints / parameters  
Goodness-of-fit on F^2          
Final R indices [I>2sigma(I)]   
R indices (all data)            
Absolute structure parameter    
Largest diff. peak and hole     
C21 H20 O5 
352.37 
100(2) K 
1.54178 A 
Orthorhombic,  P212121 
a = 5.7269(3) A   alpha = 90 deg. 
b = 8.3487(5) A    beta = 90 deg. 
c = 35.6555(17) A   gamma = 90 deg. 
1704.77(16) A^3 
4,  1.373 Mg/m^3 
0.803 mm^-1 
744 
0.15 x 0.10 x 0.04 mm 
2.48 to 66.20 deg. 
-6<=h<=5, -9<=k<=9, -42<=l<=41 
14389 / 2890 [R(int) = 0.0615] 
97.9 % 
Semi-empirical from equivalents 
0.9686 and 0.8891 
Full-matrix least-squares on F^2 
2890 / 0 / 236 
1.089 
R1 = 0.0453, wR2 = 0.1052 
R1 = 0.0525, wR2 = 0.1086 
0.3(3) 
0.175 and -0.232 e.A^-3 
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2.4. Conclusions 
In summary, we have successfully applied an iterative approach for the 
development of the new generation chiral Co(II) metalloradical catalyst [Co(P2)] that has 
proved to be generally effective for highly asymmetric intramolecular cyclopropanation. 
The [Co(P2)]-based catalytic system permits for the first time the efficient transformation 
of 　-acceptor-substituted diazoacetates into enantioenriched 3-oxabicyclo[3.1.0]hexan-
2-one derivatives bearing three contiguous stereocenters with multiple functionalities that 
may serve as valuable intermediates for stereoselective synthesis. The demonstration of 
Co(II)-based metalloradical catalysis for asymmetric intramolecular cyclopropanation 
may open the door for the discovery of other enantioselective radical cyclization 
processes, including polycyclization reactions.  
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Chapter 3 
Cobalt(II)-Catalyzed Enantioselective Intermolecular Cyclopropanation with  
α-Ketodiazoacetates 
3.1. Introduction 
Chiral carbonyl cyclopropanes are very useful synthetic precursors due to their 
exceptional reactivities.1 A number of reports have been devoted to their use in 
asymmetric synthesis (Figure 3.1) including ring rearrangement to 19,2 cycloaddition 
forming 20,3 dimerization4 or nucleophilic ring opening to 21.5 The three-membered 
rings of carbonyl cyclopropanes could be further activated in the presence of an 
additional α-electron-withdrawing group.6 gem-Dicarbonyl cyclopropane 18, a 
representative compound of such a kind, is highly desirable due to its high reactivity and 
potential retrosynthetic efficiency (Figure 3.1). A direct asymmetric synthesis of 18 may 
be expected through an enantioselective metal-catalyzed intermolecular olefin 
cyclopropanation with dicarbonyl diazo reagents. However, this process is still 
challenging mainly due to the inherently low reactivity and the perceived poor 
enantioselectivity of dicarbonyl diazo reagents.  
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Figure 3.1. Synthesis of Activated Cyclopropyl Ketones via Catalytic Asymmetric 
Cyclopropanation and their Further Transformations. 
 
So far, several enantioselective intermolecular cyclopropanation systems for gem-
dicarbonyl cyclopropanes have been developed based on rhodium catalysts (Figure 3.2, 
eq 1). Charette and coworkers first reported an asymmetric cyclopropanation reaction 
using α-amidodiazoacetate.7 Subsequently, diazomalonates were employed in catalytic 
cyclopropanation with chiral diene–rhodium complexes as catalysts.8 Later, by using a α-
PMP group, α-ketodiazoesters were reported to give the desired gem-dicarbonyl 
cyclopropanes in good enantioselectivity.5b However, in most of the reported studies to 
date, high enantioselectivity is achieved primarily through the use of specific trans- 
directing groups; large excess of reactants (5 equivalents of olefin or 3 equivalents of 
diazo) were needed for high-yielding reactions presumably due to the low reactivity of 
the diazo reagents. As a result of the trans- directing groups, the cyclopropanes made by 
these methods were predominantly (Z)-cyclopropanes (Figure 3.2, eq 1);5a, 7 whereas, the 
equally important (E)-isomers have not been produced in a selective manner. 
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Figure 3.2. Previous Syntheses of (Z)- and (E)- gem-Dicarbonyl Cyclopropanes. 
 
The family of cobalt(II) complexes of D2-symmetric chiral porphyrins [Co(D2-
Por*)] with tunable electronic, steric, and chiral environments have emerged as a new 
class of effective catalysts for various asymmetric cyclopropanation reactions.9 The 
Co(II)-based metalloradical catalysts have been shown to be highly effective for both 
asymmetric intermolecular and intramolecular cyclopropanation reactions of a broad 
scope of olefins with varied classes of diao reagents. Our previous studies revealed that 
the [Co(P7)], a new generation [Co(D2-Por*)] bearing chiral amides with two contiguous 
stereocenters, is the optimal catalyst for asymmetric intramolecular cyclopropanation 
with various α-acceptor-substituted diazoacetates, including unsaturated α-
ketodiazoacetates and diazomalonates, giving the desired products as (E)-diastereomers 
in high yields and excellent enantioselectivities (eq 2, Figure 3.2).9e Considering the 
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mechanistic similarity between intermolecular and intramolecular cyclopropanation, we 
envisioned the possibility of a (E)-selective cyclopropanation reaction with dicarbonyl 
diazo reagents such as α-ketodiazoacetates by [Co(D2-Por*)]-based catalytic system. As 
the outcome of this effort, herein, we report the first highly asymmetric synthesis of (E)-
dicarbonyl cyclopropanae using stoichiometric amount of simple α-ketodiazoacetates and 
olefins. Furthermore, a novel epimerization reaction of (E)-α-ketoester cyclopropanes to 
the corresponding (Z)-form in the same enantiomeric excess is reported. This novel 
catalytic system, along with the epimerization process, enabled the access to both 
diastereomers of gem-dicarbonyl cyclopropanes in a highly asymmetric manner.  
3.2. Results and Discussion 
3.2.1 Synthesis of (E)-Cyclopropyl Ketoesters 
The metalloradical catalyst [Co(P1)] (Table 3.1) was shown previously to be 
highly efficient for asymmetric intermolecular cyclopropanation with α-
cyanodiazoacetates9d and α-nitrodiazoacetates9c. Starting with [Co(P1)], we decided to 
evaluate its use as a potential catalyst for the cyclopropanation reaction with α-
ketodiazoacetates. The diazo compound 24 containing a bulky tert-butyl ester group was 
selected in the hope of maximizing (E)-selectivity of the reaction. Starting with 
clopropanation of styrene with diazo 24 under practical conditions (room temperature 
without slow addition), we were pleased to observe the desired (E)-dicarbonyl 
cyclopropane 25a in 88% yield, >99:1 dr and 94% ee (Table 3.1, entry 1). The absolute 
configuration of 25a was established as [1R, 2S] by anomalous-dispersion effects in X-
ray diffraction measurements on the crystal. 
76 
 
 
Table 3.1. Intermolecular Cyclopropanation of α-Ketodiazoacetates with [Co(P1)].a 
 
a Carried out in a one-portion protocol using 5 mol % [Co(P1)] under N2 at RT for 36 h 
in toluene with [olefin] = 0.20 M. Isolated yields. Enantiomeric excess of major trans 
diastereomer determined by chiral HPLC. b[1R,2S] Absolute configuration determined by 
anomalous-dispersion effects in X-ray diffraction measurements on single crystal. c 5 
equiv of olefin, d At 40 ºC. e neat reaction. f ee of minor. g Enantiomeric excess 
determined by chiral GC. 
 
The successful asymmetric cyclopropanation of styrene prompted us to study the 
scope of this catalytic system in more detail. As shown in Table 3.1, variously substituted 
styrene derivatives could also be successfully cyclopropanated under similar reaction 
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conditions, regardless of the position and electronic property of the substituent (Table 3.1, 
entries 1-7). For example, the cyclopropanation of styrene derivatives substituted with 
electron-donating MeO- as well as electron-withdrawing CF3-, NO2- and Br- groups 
reliably generated the corresponding cyclopropyl ketoesters 25b-e with essentially the 
same high stereoselectivity as the styrene product 25a. Unique catalytic properties of the 
[Co(Por)]-based system are highlighted by the formation of the expected (E)-product 
from the extremely electron-deficient pentafluorostyrene The desired product 25f was 
formed with complete control of both diastereo- and enantioselectivity, albeit with lower 
yield (Table 3.1, entry 6). 
Furthermore, styrenes with sensitive functionality such as -CHO (Table 3.1, entry 
8) and heteroaryl (Table 3.1, entry 10) were also successfully converted into the desired 
cyclopropanes with good diastereo- and enantioselectivity with no complications arising 
from potential ylide mediated reactions. The use of an α-methylstyrene allowed the 
stereoselective construction of cyclopropane 25i with two contiguous quaternary 
stereogenic centers (Table 3.1, entry 9). Finally, conjugated alkenes were tested. 
Selective cyclopropanation of the terminal double bond was observed, affording the 
corresponding vinyl cyclopropane in moderate to good yield and stereoselectivity (Table 
3.1, entries 11). Electron-deficient olefins such as α,β-unsaturated esters and cyanides, 
which have been known to be challenging to be cyclopropanated, can be asymmetrically 
cyclopropanated, albeit with diminished diastereoselectivity (Table 3.1, entries 13 and 
14). Using solvent-free conditions, an aliphatic alkene, which represents another series of 
challenging substrates for transition-metal-catalyzed cyclopropanation reactions, was also 
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successfully converted into the desired cyclopropane 25o with good diastereo- and 
enantioselectivity (Table 3.1, entry 15). 
3.2.2 Synthesis of (Z)-Cyclopropyl Ketoesters 
The resulting cyclopropyl ketone, like other electrophilic cyclopropanes,10 were 
readily reactive towards cycloadditions or nucleophilic addition reactions. Notably the 
complete preservation of the enantiomeric excess from the cyclopropane was reported 
recently using different nucleophiles such as alcohols11, amines12 or cuprate reagents5a, b. 
The proposed SN2 ring-opening mechanism is believed to be the key reason for 
preservation of chirality. In the same vein, we employed iodide, which is a good 
nucleophile and an excellent leaving group as well,13 to explore new types of 
rearrangements with preservation of the enantiomeric excess. 
As summarized in Table 3.2, the treatment of (E)-cyclopropane with 1 eq of NaI 
at 60 °C in acetone resulted in 39% yield of the (Z)-cyclopropane product (Table 3.2, 
entry 1). By increasing the molar ratio of NaI to 5.0 eq, the yield of (Z)-cyclopropane 
product was raised to 43% (Table 3.2, entry 2). The yield of (Z)-cyclopropane was further 
improved to 64% by increasing the temperature to 80 °C (Table 3.2, entry 3). 
Unfortunately, further increase in the reaction temperature caused the drop of product 
yield to 51% (Table 3.2, entry 4). Experiment with various metal iodides showed that 
metal cations played an important role in the epimerization reaction. After screening, 
sodium iodide has been proven to give the best yield and enantioselectivity (Table 3.2, 
entry 5-10). It is notable that, under the optimal reaction conditions (5.0 equiv of iodide at 
80 °C), the employment of metal ions that are strong Lewis acids, resulted in 
consumption of the starting material without the formation of the expected product (Table 
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3.2, entries 6 and 10), one possible reason for this may be that the reaction intermediate is 
highly stabilized by metal ions and shows little reactivity toward further reaction.  
 
Table 3.2. Metal Iodide Catalyzed Cyclopropane Epimerization. 
 
a GC yields with tridecane as internal standard; b Enantiomeric excess determined by 
chiral GC. 
 
After the initial success, the epimerization process was applied to afford different 
(E)-cyclopropane products. As summarized in Table 3.3, product 25d, 25e and 25j were 
successfully epimerized into their (Z)-stereoisomers with no loss of enantiomeric excess. 
We also found that this epimerization process is reversible. In order to increase the 
conversion efficiency, the remaining (E)-cyclopropane was recovered from the reaction 
mixture and underwent the same epimerization reaction for a second time, resulting in up 
to 70% combined yield. 
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Table 3.3. Synthesis of (Z)-Cyclopropyl Ketoesters. 
 
a Isolated yield after two cycles of epimerization process; b Enantiomeric excess 
determined by chiral GC; c Enantiomeric excess determined by chiral HPLC. 
 
3.2.3 Proposed Mechanism for Epimerization 
While several cyclopropane ring-opening reactions with complete preservation of 
enantiomeric excess are known,5, 11-12 the above system represents the first example of 
epimerization of chiral cyclopropane through a tandem ring-opening/closing reaction.5a 
Taking product 25a as a model, a plausible mechanism for this transformation was 
proposed as below (Figure 3.3): 
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Figure 3.3. Proposed Mechanism for Cyclopropane Epimerization. 
 
The reaction was proposed to start with an SN2 attack of iodide on C-1 of the 
cyclopropane ring, causing an inversion of the absolute configuration at C-1 and the 
three-membered ring to open. Meanwhile the carbonyl group attacked the sodium cation 
to generate intermediate I11. An intramolecular SN2 reaction of I11 was proposed to 
reconstruct the cyclopropane ring, because the stereogenic center C-3 was destroyed 
through the ring opening process, rebuilding the stereogenic center of C-3 in a 
diastereoselective manner causes the formation of both (E)- and (Z)- cyclopropanes. It is 
noteworthy to mention that the (Z)-cyclopropane product 26a could also be converted to 
(E)-form by NaI under the same condition. Thus, in the epimerization system there is an 
equilibrium between (E)- and (Z)- cyclopropanes. The diastereomeric distributions of 
cyclopropyl ketones 26a, 26d, 26e, 26j under the aforesaid equilibrium condition might 
suggest that the formation of these (Z)-cyclopropyl ketones  are thermodynamically more 
favored than their corresponding (E)-forms.  
3.3. Experimental Section 
General Considerations. All cyclopropanation reactions were carried out under a 
nitrogen atmosphere in oven-dried glassware following standard Schlenk techniques. 
Toluene was distilled under nitrogen from sodium benzophenone ketyl, other reagents 
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were direct purchased from Aldrich. Thin layer chromatography was performed on 
Merck TLC plates (silica gel 60 F254). Flash column chromatography was performed 
with ICN silica gel (60 Å, 230-400 mesh, 32-63 μm). Proton and carbon nuclear magnetic 
resonance spectra (1H NMR and 13C NMR) were recorded on a Bruker250 (250 MHz) or 
Varian Inova400 (400 MHz) or UnityInova 600 (600 MHz) instrument with chemical 
shifts reported relative to residual solvent. HPLC measurements were carried out on a 
Shimadzu HPLC system with Whelk-O1,Chiralcel OD-H, OJ-H, and AD-H columns. GC 
measurements were carried out on a Shimadzu GCMS system with Chiral GTA and Dex-
CB column. HRMS data was obtained on an Agilent 1100 LC/MS ESI/TOF mass 
spectrometer with electrospray ionization. 
 
 
tert-butyl 2-diazo-3-oxobutanoate (24):14 Triethylamine (10.8 mL, 0.077 mol) was 
added to a stirred solution of methyl 3-oxobutanoate (2.8 mL, 0.026 mol) and p-
(acetamido)benzenesulfonyl azide (p-ABSA) (6.8 g, 0.028 mol) in acetonitrile (100 mL) 
at 0 °C. The reaction was gradually warmed to room temperature overnight ,and then 
filtered, washed with hexane/ether (4:1 v/v, 50 mL), and the filtrate was then 
concentrated in vacuo, Purification of the crude residue by flash chromatography 
(hexane/ethyl acetate)on silica gel afforded the pure products (3.5 g, 95% yield) as a 
yellow oil. 1H NMR (250 MHz, CDCl3): δ 2.45 (s, 3H), 1.53 (s, 9H). 13C NMR (62.5 
MHz, CDCl3): δ 190.551, 160.601, 83.138, 28.288, 28.202. HRMS (ESI) ([M+Na]+) 
Calcd. for C8H12N2O3: 207.0740, Found: 207.0734. 
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General Procedure for Cyclopropanation: Catalyst (5 mol %) was placed in an 
oven-dried, resealable Schlenk tube. The tube was capped with a Teflon screwcap, 
evacuated, and backfilled with nitrogen. The screwcap was replaced with a rubber septum. 
1.0 Equivalents of alkene (0.10 mmol), 1.2 equivalents of diazo compound (0.12 mmol) 
in 0.5 mL toluene was added once via syringe. Schlenk tube was capped by teflon 
screwcap instead of rubber septum and stirred at room temperature. Following 
completion of the reaction, the reaction mixture was purified by flash chromatography. 
The fractions containing product were collected and concentrated by rotary evaporation 
to afford the compound. In most cases, the product was visualized on TLC using the 
cerium ammonium molybdate (CAM) stain. 
 
 
(1R,2S)-tert-butyl 1-acetyl-2-phenylcyclopropanecarboxylate (25a): 1H NMR (250 
MHz, CDCl3): δ7.13 (m, 5H), 3.10 (t, J = 8.51 Hz, 1H), 2.14 (dd, J = 7.98, 4.92 Hz, 1H), 
1.84 (s, 3H), 1.53 (dd, J = 9.03, 4.85 Hz, 1H), 1.44 (s, 9H). 13C NMR (62.5 MHz, CDCl3): 
δ 200.5, 169.5, 134.2, 128.3, 127.3, 82.5, 45.5, 33.8, 30.2, 28.1, 17.5. HPLC analysis: ee 
(E)-isomer =94%. Whelk (98.5% hexanes: 1.5% isopropanol, 0.8 ml/min) (E)-isomer: 
tmajor =9.27 min, tminor =12.67 min. HRMS (ESI) ([M+H]+) Calcd. for C16H20O3: 261.1485, 
Found: 261.1492. 
84 
 
 
Table 3.4. Crystal data and structure refinement for compound 25a  
Empirical formula                 
Formula weight                    
Temperature                       
Wavelength                        
Crystal system, space group       
Unit cell dimensions              
                                  
                                  
Volume                            
Z, Calculated density             
Absorption coefficient            
F(000)                            
Crystal size                      
Theta range for data collection   
Limiting indices                  
Reflections collected / unique    
Completeness to theta = 66.65     
Absorption correction             
Max. and min. transmission        
Refinement method                 
Data / restraints / parameters    
Goodness-of-fit on F^2            
Final R indices [I>2sigma(I)]     
R indices (all data)              
Absolute structure parameter      
Largest diff. peak and hole    
C16 H20 O3 
260.32 
100(2) K 
1.54178 A 
Orthorhombic,  P212121 
a = 5.6513(2) A   alpha = 90 deg. 
b = 9.1980(2) A    beta = 90 deg. 
c = 27.4325(6) A   gamma = 90 deg. 
1425.96(7) A^3 
4,  1.213 Mg/m^3 
0.663 mm^-1 
560 
0.20 x 0.05 x 0.05 mm 
3.22 to 68.14 deg. 
-6<=h<=6, -11<=k<=11, -32<=l<=32 
15107 / 2592 [R(int) = 0.0693] 
99.9 % 
Semi-empirical from equivalents 
0.9676 and 0.8788 
Full-matrix least-squares on F^2 
2592 / 0 / 176 
1.080 
R1 = 0.0470, wR2 = 0.1129 
R1 = 0.0506, wR2 = 0.1159 
0.2(3) 
0.186 and -0.280 e.A^-3 
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(1R,2S)-tert-butyl 1-acetyl-2-(3-nitrophenyl)cyclopropanecarboxylate (25b): 1H 
NMR (250 MHz, CDCl3): δ 8.01 (m, 2H), 7.40-7.33 (m, 2H), 3.21 (t, J = 8.48 Hz, 1H), 
2.23 (dd, J = 7.95, 5.05 Hz, 1H), 1.93 (s, 3H), 1.61 (dd, J = 8.99, 5.03 Hz, 1H), 1.47 (s, 
9H). 13C NMR (62.5 MHz, CDCl3): δ199.5, 166.7, 148.2, 136.6, 134.2, 129.2, 124.9, 
122.4, 83.1, 45.5, 33.1, 20.3, 28.1, 18.0. HPLC analysis: ee (E)-isomer =93%. Whelk 
(98.5% hexanes: 1.5% isopropanol, 0.8 ml/min) (E)-isomer: tmajor =20.78 min, tminor 
=24.74 min. HRMS (ESI) ([M+Na]+) Calcd. for C16H19NO5: 328.1155, Found: 328.1146. 
 
 
(1R,2S)-tert-butyl 1-acetyl-2-(4-methoxyphenyl)cyclopropanecarboxylate (25c): 1H 
NMR (250 MHz, CDCl3): δ 6.98 (d, J = 8.63 Hz, 2H), 6.72 (d, J = 8.69 Hz, 2H), 3.69 (s, 
3H), 3.06 (t, J = 8.53 Hz, 1H), 2.10 (dd, J = 7.96, 4.91 Hz, 1H), 1.86 (s, 3H), 1.51 (dd, J 
= 9.13, 4.90 Hz, 2H), 1.44 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ 200.7, 169.6, 158.8, 
129.4, 125.9, 113.8, 82.3, 55.2, 45.3, 33.5, 30.2, 28.1, 17.6. HPLC analysis: ee (E)-
isomer =95%. Whelk (98.5% hexanes: 1.5% isopropanol, 0.8 ml/min) (E)-isomer: tmajor 
=14.46 min, tminor =26.14 min. HRMS (ESI) ([M+Na]+) Calcd. for C17H22O4: 313.1410, 
Found: 313.1404. 
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(1R,2S)-tert-butyl 1-acetyl-2-(4-(trifluoromethyl)phenyl)cyclopropanecarboxylate 
(25d): 1H NMR (250 MHz, CDCl3): δ 7.44 (d, J = 8.17 Hz, 2H), 7.17 (d, J = 8.17 Hz, 
2H), 3.14 (t, J = 8.47 Hz, 1H), 2.17 (dd, J = 7.96, 5.01 Hz, 1H), 1.87 (s, 3H), 1.57 (dd, J 
= 8.96, 5.00 Hz, 1H), 1.45 (s, 9H).  13C NMR (62.5 MHz, CDCl3): δ199.7, 169.0, 138.4, 
129.9, 129.6, 129.305, 128.9, 128.7, 128.0, 125.3, 125.2, 125.2, 125.2, 135.1, 122.6, 82.8, 
45.7, 33.1, 30.1, 28.0, 17.8.  HPLC analysis: ee (E)-isomer =95 %. Whelk (99% hexanes: 
1% isopropanol, 0.8 ml/min) (E)-isomer: tmajor =7.94 min, tminor =9.86 min. HRMS (ESI) 
([M+Na]+) Calcd. for C17H19F3O3: 351.1178, Found: 351.1175. 
 
 
(1R,2S)-tert-butyl 1-acetyl-2-(4-bromophenyl)cyclopropanecarboxylate (25e): 1H 
NMR (250 MHz, CDCl3): δ 7.31 (d, J = 8.44 Hz, 2H), 6.93 (d, J = 8.37 Hz, 2H), 3.05 (t, 
J = 8.50 Hz, 1H), 2.11 (dd, J = 7.98, 5.00 Hz, 1H), 1.88 (s, 3H), 1.53 (dd, J = 9.03, 4.99 
Hz, 2H), 1.44 (s, 9H).  13C NMR (62.5 MHz, CDCl3): δ 199.9, 169.2, 133.2, 131.4, 129.9, 
121.3, 82.6, 45.5, 33.1, 30.2, 28.0, 17.6.  HPLC analysis: ee (E)-isomer =94%. Whelk 
(98.5% hexanes: 1.5% isopropanol, 0.8 ml/min) (E)-isomer: tmajor =9.54 min, tminor =14.40 
min. HRMS (ESI) ([M+H]+) Calcd. for C16H19BrO3: 339.0590, Found: 339.0613. 
 
 
(1R,2R)-tert-butyl 1-acetyl-2-(perfluorophenyl)cyclopropanecarboxylate (25f): 1H 
NMR (250 MHz, CDCl3): δ2.81 (t, J = 8.76 Hz, 1H), 2.21 (dd, J = 8.17, 4.77 Hz, 1H), 
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2.30 (s, 3H), 1.75 (dd, J = 9.35, 4.75 Hz, 1H), 1.47 (s, 9H).  13C NMR (62.5 MHz, CDCl3): 
δ 200.5, 168, 82.9, 41.3, 30.2, 28.0, 24.1, 24.1, 20.9, 20.8, 20.8.  HPLC analysis: ee (E)-
isomer=99%. Whelk (100% hexanes: 0% isopropanol, 0.8 ml/min) (E)-isomer: tmajor 
=12.56 min, tminor =14.30 min. 
 
 
(1R,2S)-tert-butyl 1-acetyl-2-p-tolylcyclopropanecarboxylate (25g): 1H NMR (250 
MHz, CDCl3): δ 6.96 (q, J = 8.12 Hz, 4H), 3.07 (t, J = 8.50 Hz, 1H), 2.21 (s, 3H), 2.11 
(dd, J = 7.96, 4.88 Hz, 1H), 1.85 (s, 3H), 1.50 (dd, J = 9.05, 4.87 Hz, 1H), 1.43 (s, 9H). 
13C NMR (62.5 MHz, CDCl3): δ200.5, 169.5, 136.9, 130.9, 128.9, 128.1, 82.3, 45.4, 33.6, 
30.2, 28.0, 21.0, 17.5. HPLC analysis: ee (E)-isomer =95 %. Whelk (98.5% hexanes: 1.5% 
isopropanol, 0.8 ml/min) (E)-isomer: tmajor =9.02 min, tminor =12.42 min. HRMS (ESI) 
([M+Na]+) Calcd. for C17H22O3: 297.1461, Found: 297.1462. 
 
 
(1R,2S)-tert-butyl 1-acetyl-2-(3-formylphenyl)cyclopropanecarboxylate (25h): 1H 
NMR (250 MHz, CDCl3): δ 9.91 (s, 1H), 7.72-7.58 (m, 2H), 7.34 (td, J = 9.05, 7.70 Hz, 
2H), 3.19 (t, J = 8.51 Hz, 1H), 2.22 (dd, J = 7.98, 5.01 Hz, 1H), 1.88 (s, 3H), 1.59 (dd, J 
= 9.02, 4.99 Hz, 2H), 1.46 (s, 9H) 13C NMR (62.5 MHz, CDCl3): δ199.9, 192.1, 169.1, 
136.4, 135.6, 134.1, 129.8, 129.0, 128.8, 82.8, 45.5, 33.3, 30.2, 28.0, 17.7, HPLC 
analysis: ee (E)-isomer= 94 %. Whelk (95% hexanes: 5% isopropanol, 0.8 ml/min) (E)-
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isomer: tmajor =20.87 min, tminor =25.06 min. HRMS (ESI) ([M+Na]+) Calcd. for C17H20O4: 
311.1254, Found: 311.1259. 
 
 
(1R,2S)-tert-butyl 1-acetyl-2-methyl-2-phenylcyclopropanecarboxylate (25i): 1H 
NMR (250 MHz, CDCl3): δ 7.15 (m, 5H), 2.22 (d, J = 4.96 Hz, 1H), 2.04 (s, 3H), 1.47 
(m, 13H). 13C NMR (62.5 MHz, CDCl3): δ 200.2, 168.5, 140.6, 128.3, 128.2, 127.0, 82.1, 
49.7, 40.1, 30.5, 28.2, 28.1, 24.0, 23.9. HPLC analysis: ee (E)-isomer =87 %. Whelk (97% 
hexanes: 3% isopropanol, 0.8 ml/min) (E)-isomer: tmajor =10.01 min, tminor =16.24 min. 
HRMS (ESI) ([M+Na]+) Calcd. for C17H20O3: 297.1461, Found: 297.1464. 
 
 
tert-butyl 3-((1S,2R)-2-acetyl-2-(tert-butoxycarbonyl)cyclopropyl)-1H-indole-1-
carboxylate (25j): 1H NMR (400 MHz, CDCl3): δ 8.07 (d, J = 1.20 Hz, 1H), 7.58 (d, J = 
7.79 Hz, 1H), 7.25 ( m, 3H), 3.15 (dt, J = 8.46, 8.08, 0.96 Hz, 1H), 2.15 (dd, J = 7.95, 
4.54 Hz, 1H), 1.92 (s, 3H), 1.63 (s, 9H), 1.53 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ 
200.1, 169.6, 149.4, 130.5, 124.6, 123.9, 122.6, 118.4, 115.4, 114.4, 83.8, 82.4, 44.4, 29.9, 
28.1, 28.0, 25.2, 17.4. HPLC analysis: ee (E)-isomer =95%. Whelk (99% hexanes: 1% 
isopropanol, 0.8 ml/min) (E)-isomer: tmajor =20.54 min, tminor =29.14 min. HRMS (ESI) 
([M+Na]+) Calcd. for C23H29NO5: 422.1938, Found: 422.1937. 
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(1R,2S)-tert-butyl 1-acetyl-2-styrylcyclopropanecarboxylate (25k): 1H NMR (400 
MHz, CDCl3): δ7.21 (tt, J = 7.72, 4.28 Hz, 5H), 6.63 (d, J = 15.81 Hz, 1H), 5.62 (dd, J = 
15.81, 9.41 Hz, 1H), 2.69 (dd, J = 16.53, 9.02 Hz, 1H), 2.29 (s, 3H), 1.87 (dd, J = 7.39, 
4.56 Hz, 1H), 1.53 (dd, J = 9.05, 4.84 Hz, 1H), 1.48 (s, 9H). 13C NMR (62.5 MHz, 
CDCl3): δ 201.6, 169.3, 136.6, 133.7, 128.5, 127.5, 126.0, 124.6, 82.4, 43.9, 33.1, 30.5, 
28.0, 20.6. HPLC analysis: ee (E)-isomer =79 %. Whelk (99% hexanes: 1% isopropanol, 
0.8 ml/min) (E)-isomer: tmajor =12.47 min, tminor =14.94 min. HRMS (ESI) ([M+Na]+) 
Calcd. for C18H22O3: 309.1461, Found: 309.1466. 
 
 
(1R,2S)-tert-butyl 1-acetyl-2-((E)-3-ethoxy-3-oxoprop-1-enyl)cyclopropanecarboxyl-
ate (25l): Major isomer:1H NMR (400 MHz, CDCl3): δ 6.55 (dd, J = 15.52, 9.91 Hz, 1H), 
6.01 (d, J = 15.56, 1H), 4.24-4.05 (m, 2H), 2.71-2.53 (m, 1H), 2.28 (s, 3H), 1.84 (dd, J = 
7.14, 4.62 Hz, 1H), 1.56 (m, 1H), 1.46 (s, 9H), 1.24 (t, J = 7.14 Hz, 3H). Minor isomer: 
1H NMR (400 MHz, CDCl3): δ 6.30 (dd, J = 15.49, 10.06 Hz, 1H), 6.01 (dd, J = 15.56, 
4.89 Hz, 1H), 4.24-4.05 (m, 2H), 2.71-2.53 (m, 1H), 2.39 (s, 3H), 1.75 (dd, J = 7.26, 4.46 
Hz, 1H), 1.56 (m, 1H), 1.46 (s, 9H), 1.24 (t, J = 7.14 Hz, 3H).  13C NMR (62.5 MHz, 
CDCl3): δ 200.6, 199.4, 167.6, 166.3, 164.6, 164.5, 142.8, 142.1, 123.3, 123.0, 82.0, 81.9, 
59.4, 59.3, 43.7, 43.4, 30.5, 30.0, 29.3, 28.4, 26.9, 26.9, 22.6, 19.8, 13.2, 0.1.  HPLC 
analysis: ee (major) =80 %. Whelk (99% hexanes:1 % isopropanol, 0.8 ml/min): tmajor 
=29.93 min, tminor =34.44 min. ee (minor) =90 %. Whelk (99% hexanes:1 % isopropanol, 
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0.8 ml/min): tmajor =39.14 min, tminor =35.97 min. HRMS (ESI) ([M+Na]+) Calcd. for 
C15H22O5: 305.1359, Found: 305.1355. 
 
 
(1R,2R)-1-tert-butyl 2-methyl 1-acetylcyclopropane-1,2-dicarboxylate (25m): Major 
isomer: 1H NMR (250 MHz, CDCl3): δ 3.64 (s, 3H), 2.21 (s, 3H), 2.53-2.44 (m, 1H), 
1.86-1.78 (m, 1H), 1.48 (m, 1H), 1.39 (s, 9H). Minor isomer: 1H NMR (250 MHz, 
CDCl3): δ 3.63 (s, 3H), 2.30 (s, 3H), 2.53-2.44 (m, 1H), 1.86-1.78 (m, 1H), 1.48 (m, 1H), 
1.43 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ200.8, 199.1, 170.0, 169.8, 167.9, 166.6, 
83.3, 82.6, 52.4, 52.2, 44.6, 43.0, 29.5, 29.3, 28.6, 28.1, 27.9, 27.7, 21.2, 19.1. HPLC 
analysis: ee (minor) =93 %. Whelk (98.5% hexanes: 1.5% isopropanol, 0.8 ml/min): tmajor 
=23.25 min, tminor =24.90 min. HRMS (ESI) ([M+Na]+) Calcd. for C12H18O5: 265.1046, 
Found: 265.1046. 
 
 
(1R,2R)-tert-butyl 1-acetyl-2-cyanocyclopropanecarboxylate (25n):Major isomer: 1H 
NMR (250 MHz, CDCl3): δ 2.44 (dd, J = 9.37, 7.11 Hz, 1H), 2.39 (s, 3H), 1.91 (dd, J = 
7.09, 4.61 Hz, 1H), 1.497 (s, 9H),   1.464 (m, 1H), Minor isomer: 1H NMR (250 MHz, 
CDCl3): δ 2.43 (s, 3H), 2.32 (dd, J = 9.28, 7.03 Hz, 1H), 2.00 (dd, J = 7.01, 4.78 Hz, 1H), 
1.552 (m, 1H), 1.43 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ 199.4, 197.4, 166.5, 165.2, 
116.7, 116.4, 84.5, 84.4, 41.4, 41.3, 29.4, 29.2, 27.9, 21.6, 19.2, 12.7, 12.7. GC analysis: 
ee (major) = 66 %. CP-Chirasil-Dex CB (Temp program: initial temp = 50° C, hold time 
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= 5 min, Rate: 5.00° C/min, max temp =200° C, hold time= 5 min) tminor = 23.67 min, 
tmajor = 23.34 min. ee (minor) = 66 %. CP-Chirasil-Dex CB (Temp program: initial temp 
= 50° C, hold time = 5 min, Rate: 5.00° C/min, max temp =200° C, hold time= 5 min) 
tminor = 25.00 min, tmajor = 25.44 min. HRMS (ESI) ([M+H]+) Calcd. for C11H15NO3: 
210.1125, Found: 210.1125. 
 
 
(1R,2R)-tert-butyl 1-acetyl-2-hexylcyclopropanecarboxylate (25o): 1H NMR (600 
MHz, CDCl3): δ  2.33 (s, 3H), 1.90-1.82 (m, 1H), 1.44 (s, 9H), 1.43-1.40 (m, 1H), 1.39-
1.16 (m, 10H), 1.04-0.94 (m, 1H), 0.84 (t, J = 7.06 Hz, 3H).  13C NMR (62.5 MHz, 
CDCl3): δ  201.4, 169.4, 80.8, 40.8, 30.6, 29.9, 29.7, 28.3, 27.9, 27.0, 26.3, 21.5, 19.5, 
13.0.  GC analysis: ee (E)-isomer = 78 %. CP-Chirasil-Dex CB (Temp program: initial 
temp = 50° C, hold time = 5 min, Rate: 3.00° C/min, max temp =200° C, hold time= 5 
min) (E)-isomer: tminor = 39.36 min, tmajor = 39.21 min. HRMS (ESI) ([M+Na]+) Calcd. 
for C16H28O3: 291.1931, Found: 291.1931. 
 
General Procedure for Epimerization. To a solution of (E)-cyclopropane (0.1 
mmol) in acetone (1 ml) was added NaI (0.5 mmol). The mixture was refluxed at 80 °C 
for 20 h.  The resulting mixture was concentrated and the residue was dissolved in ethyl 
acetate, and then washed with water. The organic layer was concentrated, followed by 
flash silica gel chromatography to separate the (Z)- and (E)-cyclopropane. In order to 
increase conversion efficiency, the (E)-cyclopropane was recovered for a second 
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epimerization process. (Z)-cyclopropane from two epimerization was combined to give 
the final product.  
 
 
(1S,2S)-tert-butyl 1-acetyl-2-phenylcyclopropanecarboxylate (26a): 1H NMR (400 
MHz, CDCl3): δ  7.28-7.16 (m, 5H), 3.23 (t, J = 8.57 Hz, 1H), 2.43 (s, 3H), 2.13 (dd, J = 
8.07, 4.54 Hz, 1H), 1.61 (dd, J = 9.09, 4.54 Hz, 1H), 1.07 (s, 9H). 13C NMR (62.5 MHz, 
CDCl3): δ  202.9, 167.2, 134.9, 129.2, 128.1, 127.3, 81.8, 45.6, 34.8, 29.6, 27.5, 21.1. GC 
analysis: ee (Z)-isomer = 95 %. CP-Chirasil-Dex CB (Temp program: initial temp = 50° 
C, hold time = 5 min, Rate: 5.00° C/min, max temp =200° C, hold time= 5 min) (Z) -
isomer: tminor = 29.44 min, tmajor = 29.60 min. HRMS (ESI) ([M+Na]+) Calcd. for 
C16H20O3: 283.1305, Found: 283.1309. 
 
 
(1S,2S)-tert-butyl 1-acetyl-2-(4-(trifluoromethyl)phenyl)cyclopropanecarboxylate 
(26d): 1H NMR (600 MHz, CDCl3): δ  7.51 (d, J = 8.18 Hz, 2H), 7.30 (d, J = 8.00 Hz, 
2H), 3.26 (t, J = 8.46 Hz, 1H), 2.13 (dd, J = 8.01, 4.76 Hz, 1H), 2.42 (s, 3H), 1.61 (dd, J 
= 9.00, 4.74 Hz, 1H), 1.07 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ  202.3, 166.7, 139.2, 
130.3, 129.8, 129.4, 129.2, 128.7, 125.0, 124.9, 124.9, 124.8, 121.9, 82.2, 45.6, 33.5, 29.6, 
27.4, 21.0. GC analysis: ee (Z)-isomer = 97 %. CP-Chirasil-Dex CB (Temp program: 
initial temp = 50° C, hold time = 5 min, Rate: 5.00° C/min, max temp =200° C, hold 
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time= 5 min) (Z) -isomer: tminor = 28.68 min, tmajor = 28.96 min. HRMS (ESI) ([M+Na]+) 
Calcd. for C17H19F3O3: 351.1178, Found: 351.1174. 
 
 
(1S,2S)-tert-butyl 1-acetyl-2-(4-bromophenyl)cyclopropanecarboxylate(26e) 
1H NMR (400 MHz, CDCl3): δ  7.38 (d, J = 8.43 Hz, 2H), 7.06 (d, J = 8.07 Hz, 2H), 3.16 
(t, J = 8.52 Hz, 1H), 2.41 (s, 3H), 2.06 (dd, J = 8.03, 4.64 Hz, 1H), 1.58 (dd, J = 9.06, 
4.66 Hz, 1H), 1.11 (s, 9H), 13C NMR (100 MHz, CDCl3): δ  202.4, 166.8, 134.0, 131.0, 
130.7, 121.1, 82.0, 45.4, 33.6, 29.5, 27.4, 21.0. GC analysis: ee (Z)-isomer = 96 %. CP-
Chirasil-Dex CB (Temp program: initial temp = 50° C, hold time = 5 min, Rate: 5.00° 
C/min, max temp =200° C, hold time= 5 min) (Z) -isomer: tminor = 34.50 min, tmajor = 
34.60 min. HRMS (ESI) ([M+Na]+) Calcd. for C16H19BrO3: 361.0410, Found: 361.0408. 
 
 
tert-butyl 3-((1S,2S)-2-acetyl-2-(tert-butoxycarbonyl)cyclopropyl)-1H-indole-1-
carboxylate(26j): 1H NMR (400 MHz, CDCl3): δ  8.07 (d, J = 7.24 Hz, 1H), 7.52 (d, J = 
7.63 Hz, 1H), 7.25 (m, J = 21.15, 11.17 Hz, 53H), 3.15 (t, J = 8.10 Hz, 1H), 2.45 (s, 3H), 
2.04 (dd, J = 7.56, 4.11 Hz, 1H), 1.63 (s, 9H), 0.94 (s, 9H). 13C NMR (100 MHz, CDCl3): 
δ  202.7, 167.0, 149.4, 135.3, 130.7, 124.6, 123.9, 122.4, 119.5, 115.8, 115.0, 83.6, 81.7, 
44.7, 29.6, 28.1, 27.1, 25.4, 21.0. HPLC analysis: ee (Z)-isomer =93 %. OD-H (99% 
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hexanes: 1% isopropanol, 0.8 ml/min) (Z) -isomer: tmajor =7.54 min, tminor =7.01 min. 
HRMS (ESI) ([M+Na]+) Calcd. for C23H29NO5: 422.1938, Found: 422.1942. 
 
3.4. Conclusions 
In summary, we have successfully applied tert-butyl diazoacetoacetate for highly 
asymmetric cyclopropanation. The [Co(P1)]-based catalytic system permits for the first 
time the efficient transformation of (E)-cyclopropyl ketones bearing multiple 
functionalities that may serve as valuable intermediates for stereoselective synthesis. The 
detection of metal iodide catalyzed cyclopropane ring epimerization may provide another 
novel pathway for cyclopropane transformations.  
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Chapter 4 
Cobalt(II)-Catalyzed Enantioselective Intermolecular Cyclopropanation with α-
Formyldiazoacetates  
4.1. Introduction 
Cyclopropane carbaldehydes 27 (Figure 4.1) are a class of interesting compounds. 
In addition to their potential biology activeities,1 the presence of both cyclopropane and 
aldehyde functionalities makes them extremely versatile synthons (Figure 4.1).2 As the 
aldehyde functionality can be easily transformed into a number of other functional groups 
including alcohols, carboxylic acids and olefins, cyclopropane carbaldehydes provide 
straightforward accesses to different cyclopropane derivatives. Given that cyclopropanes 
resemble alkenes in many aspects, they can function as the equivalence of α,β-
unsaturated carbonyls for homoconjugate nucleophilic addition to furnish 1,3-
difunctional products in a single step.2i, j, 3  
 
98 
 
 
Figure 4.1. Versatile Transformations of Cyclopropane Carbaldehdes. 
 
As shown in Figure 4.2, there have been a number of procedures reported in 
literature leading to enantiopure cyclopropane carbaldehydes. They include i) Michael-
initiated ring-closure reaction (MIRC) from substituted acroleins4 (Figure 4.2, pathway 
a); ii) functional group transformation from pre-existing enantiopure cylcopropyl rings5 
(Figure 4.2, pathway b-d); iii) intramolecular cyclization from chiral homoallylic 
alcohols6 (Figure 4.2, pathway f); and iv) enantioselective hydroformylation from 
cyclopropenes7 (Figure 4.2, pathway e). With the recent developments in carbene 
chemistry, a direct pathway to functionalized cyclopropanes have become common. In 
spite of these developments, cyclopropane carboxaldehydes are still rarely shown via this 
method using formyl diazo compounds. A possible explanation for this might be the 
competition reaction of carbonyl ylide formation from metallocarbene with carbonyl 
group.8 Both intermolecular9 and intramolecular carbonyl ylide formation10 have been 
reported as intermediates in the synthesis of heterocycles. To the best of our 
acknowledgement, the only reported metal-catalyzed cyclopropanation using formyl 
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diazoacetates was by Wenkert and coworkers in 1990 wherein a non-chiral dirhodium 
tetraacetate was utilized as catalyst leading to only 19% yield of the desired cyclopropyl 
aldehyde.11 
 
 
Figure 4.2. Synthetic Pathways to Cyclopropane Carbaldehdes. 
 
The family of cobalt(II) D2-symmetric chiral porphyrins [Co(Por)] with tunable 
electronic, steric, and chiral environments has emerged as a new class of effective 
catalysts for various asymmetric cyclopropanation reactions.12 These metalloradical 
catalysts have been shown to be highly effective for both asymmetric intermolecular and 
intramolecular cyclopropanation of a broad scope of substrates with different classes of 
carbene sources.12-13 It is evident that Co(II)-based metalloradical cyclopropanation 
possesses a distinct reactivity profile from the widely studied Rh2- and Cu-based closed-
shell systems. Unlike other electrophilic metallocarbene system, the Co(II)-based 
metallocarbene features a high degree of functional group tolerance. For example, an 
aldehyde group was well tolerated in Co(II)-based metalloradical cyclopropanation 
reaction without complication from potential ylide mediated epoxidation.14 In view of 
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this and other related results, we envisioned the possibility of using formyl diazo reagents 
in cyclopropanation for direct synthesis of cyclopropane carbaldehydes. With the success 
of enantioselective cyclopropanation of various olefins with acceptor/acceptor diazo 
reagents, we chose to initially target cyclopropanation with formyl diazoacetate, which 
would generate an activated cyclopropane carbaldehyde bearing two gem-substituted 
electron-accepting groups. 
4.2. Results and Discussion  
Vilsmeier reactions with diazoacetate generating formyl diazoacetate is the most 
widely used method to synthesize α-formyldiazoacetates, this reaction was first reported 
by Stojanovic and Arnold fifty years ago.15 According to the reported procedure, different 
α-formyldiazoacetates was synthesized in moderate yield (Figure 4.3). The convenient 
straightforward syntheses of diazo compound build the foundation of this work.   
 
Figure 4.3. Synthesis of Formyl Diazoacetates. 
 
4.2.1 Synthesis of Cyclopropyl Aldehydes 
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Figure 4.4. The Family of Cobalt(II) Porphyrin Complexes. 
 
Among this family of ([Co(Por*)]), a group of six derivatives (Figures 4.4), 
possess diverse electronic, steric, and chiral environments, were evaluated as potential 
catalysts for asymmetric  cyclopropanation of styrene with the ethyl 2-diazo-3-
oxopropanoate. As the results demonstrated in Table 4.1, there exists a significant 
dependence of catalytic activity on the bulky nature of the ligand. For example, 
employing [Co(P1)] as catalyst, we found the cyclopropanation process proceeded 
efficiently with moderate diastereoselectivity and enantioselectivity (Table 4.1, entry 1), 
sterically similar [Co(P2)] and [Co(P8)] catalyzed the reaction with similar yields and 
enantioselectivities (Table 4.1, entries 2 and 7). Catalysts with considerably more 
sterically encumbered ligands ([Co(P4-P5)]) were unable to effectively catalyze the 
reaction (Table 4.1, entries 4-7). Of all the catalyst screened, [Co(P7)] seems to be the 
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most ideal catalyst for the cyclopropanation reaction. Upon the discovery of [Co(P7)] as 
the most effective catalyst, several solvents were evaluated for their effect on the 
selectivity and efficiency of the cyclopropanation process, toluene was selected as it 
provide the greatest enantioselectivity (96% ee) and high yield (99% yield). However, the 
diastereoselectivity was only moderate (Table 4.1, entry 8). 
 
Table 4.1. Cyclopropanation with Ethyl 2-diazo-3-oxopropanoate by Chiral Cobalt(II) 
Porphyrins.a 
 
a Performed at 40 oC for 12 h using 2 mol % of catalyst; [substrate] = 0.2 M. b Isolated 
yields. c NMR yields. d dr and ee determined by chiral HPLC. e ee of major diastereomer. 
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To further improve the diastereoselectivity, we choose to enlarge the ester group 
on formyl diazoacetate, thus, tert-butyl 2-diazo-3-oxopropanoate 44b was synthesized 
from tert-butyl diazoacetate. As expected, with [Co(P1)] as catalyst, the 
diastereoselectivity of desired cyclopropane was bounced up to 6:94, while maintaining 
the high ee (Figure 4.5), although the yield diminished a small amount, increasing the 
catalyst loading can negate this decrease. 
 
 
Figure 4.5. Enantioselective Cyclopropanation with tert-butyl 2-diazo-3-oxopropanoate. 
 
With the success of asymmetric cyclopropanation of styrene, the scope of this 
catalytic system was then investigated in detail. As summarized in Table 4.2, styrene 
derivatives bearing substituents at different positions with varied electronic properties 
could also be successfully cyclopropanated under similar reaction conditions (Table 4.2, 
entries 1-9 and 11). For example, the cyclopropanation of styrene derivatives substituted 
with alkyl groups as well as electron-withdrawing such as CF3-, NO2-, F- and Br- groups 
could all productively generate the corresponding cyclopropane carbaldehydes with 
excellent enantioselectivities. The use of α-methylstyrene allowed the stereoselective 
construction of a cyclopropane structure containing two contiguous quaternary 
stereogenic centers (Table 4.2, entry 10). In addition, electron-deficient olefins such as 
α,β-unsaturated esters, which are typically challenging substrates, could be 
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cyclopropanated as well, but with diminished diastereoselectivity (Table 4.2, entries 12 
and 13).  
 
Table 4.2. Synthesis of Cyclopropyl Aldehydes. a,b,c 
 
a Reaction conditions: Performed at 40 oC for 20 h in one-time fashion without slow 
addition of the diazo reagent using 5 mol % of Co(P1) under N2 with 1.2 equiv of diazo 
reagent and 1.0 equiv of alkene. [substrate] = 0.2 M. b Isolated yields. c ee of major 
diastereomer determined by chiral HPLC or GC. d ee determined after further 
transformation. e 5 equiv of olefin used.  
 
4.2.2. Enantioselective Synthesis of Dihydrofurans 
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During the process of investigating the substrate scope, a side product was 
observed that has led us to develop the enantioselective synthesis of diyhydrofurans. 
When cobalt-catalyzed cyclopropanation was applied to more electron-sufficient olefins, 
the isolated major product from the reaction was found to be dihydrofurans instead of 
cyclopropanes. As shown in Table 4.3, with 4-methyl styrene, only 10% dihydrofuran 
was isolated, the major product is still cyclopropane (Table 4.3, entry 3), but change from 
4-methyl styrene to 4-methoxy styrene, the major product isolated was dihydrofuran 
(Table 4.3, entry 2), if vinyl ether was applied, the only product isolated was 
dihydrofuran (Table 4.3, entry 1). It was also observed that enantioselectivity of the 
isolated dihydrofuran varies substantially among the substrates. For example, the 
dihydrofuran 47c from 4-methyl styrene could achieve 99% ee, although with only 10% 
yield; with 4-methoxy styrene, ee dropped to 39%, and ee continue to drop when a more 
electron rich olefin such as vinyl ether was used.  
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Table 4.3. Observation of Dihydrofuran from Cyclopropanation Catalytic System.a 
 
a Reaction conditions: Performed at 40 oC for 20 h in one-time fashion without slow 
addition of the diazo reagent using 5 mol % of [Co(P1)] under N2 with 1.2 equiv of diazo 
reagent and 1.0 equiv of alkene. [substrate] = 0.2 M. b 5 equiv of olefin used c Isolated 
yied. d ee determined by chiral HPLC.  
 
The absence of effective enantioselective dihydrofuran formation with formyl 
diazoacetate may be attributed to two possibilities: (i) poor chiral induction from the 
[Co(Por)]-catalyzed cyclization process, or (ii) complications resulting from the thermal 
rearrangement from cyclopropane to furan.11, 16 The first possibility is not obvious given 
the fact that, the dihydrofuran generated from 4-methyl styrene bearing a 99% ee (Table 
4.3, entry 3), the latter possibility, however, has been observed before, with partial 
racemization.16 It was found that cyclopropane 45b was quantitatively transferred to 
dihydrofuran 47b during overnight at room temperature. In comparison, higher 
temperature and longer reaction time were needed to transform cyclopropane 45c into its 
corresponding dihydrofuran (Figure 4.6). The varied reactivity might attribute to the 
different substituent (4-methoxy phenyl and 4-methyl phenyl) on the cyclopropane, as a 
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type of donor-accepter cyclopropane, the reactivity imparted to the cyclopropane by the 
substituents is influenced by the synergistic electron ‘push–pull’ relationship, the stronger 
this relationship is, the easier ring open would be. 17 Along with the thermal ring open 
process, partial racemization is unpreventable.16 Combine both experimental results, it 
become evident that the latter possibility might be the major reason cause the low ee 
outcome of dihydrofuran. However, until now, this non-enantioselective thermally 
rearrangement process still cannot be controlled. 
 
 
Figure 4.6. Thermal Rearrangement of Cyclopropanes to Furans. 
 
4.2.3. Mechanism 
Based on the recent detailed mechanistic study that confirmed the involvement of 
an unusual Co(III)-carbene radical as the key intermediate and elucidated an 
unprecedented stepwise radical addition-substitution pathway for the Co(II)-catalyzed 
olefin cyclopropanation,18 we proposed a mechanism of these cyclization reactions 
(Figure 4.7). The interaction of the formyl diazoacetate with the cobalt(II) complex 
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liberates nitrogen gas and generates the cobalt(III)-carbene radical species I11; the 
subsequent interaction with the olefin allows for the formation of the benzylic radical 
intermediate I12; and through a kinetically fast ring closing step we are able to observe  
cyclopropane 45. Conversely, a slow ring closing step would result in an alternative 
catalytic pathway, the benzyl radical intermediate I12 would undergo a consecutive 
addition reaction to the aldehyde group and produce dihydrofuran 47 as the product. Both 
radical additions pathways should be enatioselective because of the surrounding chiral 
environment.  
 
 
Figure 4.7. Proposed Mechanism for Cyclopropanation and Dihydrofuran Formation. 
 
4.3. Experimental Section 
General Considerations. All cyclopropanation reactions were carried out under a 
nitrogen atmosphere in oven-dried glassware following standard Schlenk techniques. 
Toluene was distilled under nitrogen from sodium benzophenone ketyl. Thin layer 
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chromatography was performed on Merck TLC plates (silica gel 60 F254). Flash column 
chromatography was performed with ICN silica gel (60 Å, 230-400 mesh, 32-63 μm). 
Proton and carbon nuclear magnetic resonance spectra (1H NMR and 13C NMR) were 
recorded on a Bruker250 (250 MHz) or Varian Inova400 (400 MHz) or UnityInova 600 
(600 MHz) instrument with chemical shifts reported relative to residual solvent. HPLC 
measurements were carried out on a Shimadzu HPLC system with Whelk-O1,Chiralcel 
OD-H, OJ-H, and AD-H columns. GC measurements were carried out on a Shimadzu 
GCMS system with Chiral GTA and Dex-CB column. HRMS data was obtained on an 
Agilent 1100 LC/MS ESI/TOF mass spectrometer with electrospray ionization. 
 
 
 
Diazo Synthesis:15 In a dried three-necked flask is placed a CHC13 solution of 
DMF (1.1 g, 15 mmol/30 ml). While stirring in a freezing mixture, 2.2 g of oxalyl 
chloride (18 mmol) was added dropwise. After the vigorous evolution of CO and CO2 has 
ceased, the mixture was heated to 40 °C for 10 min. The mixture was then cooled to -
10 °C and diazoacetate (30 mmol) was added dropwise, maintaining the temperature no 
higher than 0 °C. After the brisk evolution of N2 has subsided, the mixture was stirred at 
r.t. for 1 h. The solution was concentrated, and 100 ml of cold dry Et2O were added. The 
formed crystals were filtered immediately, washed successively with dry Et2O and then 
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dissolved in 10% aq. AcOH. After stirring for 2 h, the mixture was extracted with Et2O, 
washed with brine, dried with Na2SO4, filtered, and concentrated, followed by flash silica 
gel chromatography (pentane/diethyl ether) to afford desired product. 
 
 
ethyl 2-diazo-3-oxopropanoate (44a): 1H NMR (250 MHz, CDCl3): δ 9.63 (s, 1H), 4.29 
(dq, J = 7.11, 1.32 Hz, 2H), 1.28 (dt, J = 7.13, 1.32 Hz, 3H). 13C NMR (62.5 MHz, 
CDCl3): δ 181.3, 161.2, 61.9, 14.3. 
 
 
tert-butyl 2-diazo-3-oxopropanoate(44b): 1H NMR (250 MHz, CDCl3): δ 9.66 (s, 1H), 
1.52 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ 181.8, 160.3, 83.9, 28.3. 
 
General Procedure for Cyclopropanation: Catalyst (5 mol %) was placed in an 
oven-dried, resealable Schlenk tube. The tube was capped with a Teflon screwcap, 
evacuated, and backfilled with nitrogen. The screwcap was replaced with a rubber septum. 
1.0 Equivalents of alkene (0.10 mmol), 1.2 equivalents of diazo compound (0.12 mmol) 
in 0.5 ml toluene was added once via syringe. Schlenk tube was capped by teflon 
screwcap instead of rubber septum and stirred at room temperature. Following 
completion of the reaction, the reaction mixture was purified by flash chromatography. 
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The fractions containing product were collected and concentrated by rotary evaporation 
to afford the compound. In most cases, the product was visualized on TLC using the 
cerium ammonium molybdate (CAM) stain. 
 
 
 
General Procedure for The Reduction of Cyclopropane Carbaldehydes: In 
some cases, a further reduction step is needed for the determination of ee. To a stirred at 
0 °C solution of cyclopropyl aldehydes (0.1 mmol) in methanol (5 ml) was added 
dropwise a solution of sodium borohydride (1.2-1.5 equiv.) in methanol (1 ml). The 
mixture was stirred for 10 min at 0 °C, and then quenched by 3N aqueous NaOH (3 ml), 
the mixture was then extracted by ethyl acetate (3 x 5 ml), and the combined organic 
phases were washed with brine, dried with Na2SO4, filtered, and concentrated. 
Purification of the crude residue by flash silica gel chromatography afforded the 
corresponding alcohol  
 
 
tert-butyl 1-formyl-2-phenylcyclopropanecarboxylate(46a):1H NMR (250 MHz, 
CDCl3): δ 9.85 (s, 1H), 7.25-7.08 (m, 6H), 3.29 (t, J = 8.91 Hz, 1H), 2.26 (dd, J = 8.70, 
4.35 Hz, 1H), 1.90 (dd, J = 9.11, 4.34 Hz, 1H), 1.48 (s, 9H). 13C NMR (62.5 MHz, 
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CDCl3): δ 195.4, 169.6, 133.1, 129.7, 128.1, 127.7, 82.5, 42.0, 41.3, 28.2, 19.9. HPLC 
analysis: ee =96 %. OJ-H (97% hexanes: 3% isopropanol, 0.8 ml/min) tmajor =20.43 min, 
tminor =16.50 min. 
 
 
tert-butyl 1-formyl-2-p-tolylcyclopropanecarboxylate(46b): 1H NMR (400 MHz, 
CDCl3): δ9.84 (s, 1H), 7.09 (m, 4H), 3.26 (t, J = 8.90 Hz, 1H), 1.88 (dd, J = 9.09, 4.30 
Hz, 1H), 2.26-2.20 (m, 4H), 1.48 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ 195.5, 169.7, 
137.4, 130.0, 129.5, 128.8, 82.5, 42.2, 41.4, 28.4, 28.2, 21.2, 19.9. 
 
 
tert-butyl 1-(hydroxymethyl)-2-p-tolylcyclopropanecarboxylate(46ba): 1H NMR (250 
MHz, CDCl3): δ 7.05 (m, 4H), 3.40 (ddd, J = 12.33, 2.91, 0.92 Hz, 1H), 3.26 (dd, J = 
12.32, 5.27 Hz, 1H), 2.82 (br, 1H), 2.25 (s, 3H),1.51 (dd, J = 8.69, 4.58 Hz, 1H), 1.44 (s, 
9H), 1.28 (dd, J = 7.14, 4.75 Hz, 1H). 13C NMR (62.5 MHz, CDCl3): δ 173.8, 136.6, 
132.9, 129.0, 129.0, 81.4, 62.3, 32.3, 30.5, 28.2, 21.1, 17.4, HPLC analysis: ee =97 %. 
Whelk (99% hexanes: 1% isopropanol, 0.8 ml/min) tmajor = 24.24 min, tminor = 28.18min. 
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tert-butyl 2-(4-tert-butylphenyl)-1-formylcyclopropanecarboxylate(46c): 1H NMR 
(250 MHz, CDCl3): δ 9.84 (s, 1H), 7.26-7.19 (m, 2H), 7.07 (d, J = 8.24 Hz, 2H), 3.25 (t, 
J = 8.97 Hz, 1H), 2.25 (dd, J = 8.74, 4.36 Hz, 1H), 1.89 (dd, J = 9.10, 4.32 Hz, 1H), 1.48 
(s, 9H), 1.23 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ 195.5, 169.7, 150.6, 130.0, 129.3, 
125.067, 82.5, 42.3, 41.3, 34.5, 31.3, 28.2, 19.8. HPLC analysis: ee = 97%. Whelk (99% 
hexanes: 1% isopropanol, 0.8 ml/min) tmajor = 11.56 min, tminor = 33.36 min. 
 
 
tert-butyl 1-formyl-2-m-tolylcyclopropanecarboxylate(46d): 1H NMR (250 MHz, 
CDCl3): δ 9.84 (s, 1H), 7.15-6.86 (m, 5H), 1.88 (dd, J = 9.09, 4.36 Hz, 1H), 2.25 (dd, J = 
14.24, 5.67 Hz, 1H), 2.25 (s, 3H) 3.26 (t, J = 8.93 Hz, 1H), 1.48 (s, 9H). 13C NMR (62.5 
MHz, CDCl3): δ 195.5, 169.7, 137.7, 133.0, 130.4, 128.4, 128.0, 126.6, 82.5, 42.0, 41.3, 
28.2, 21.4, 19.8.  
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tert-butyl 1-(hydroxymethyl)-2-m-tolylcyclopropanecarboxylate(46da): 1H NMR 
(250 MHz, CDCl3): δ 7.17-6.91 (m, 4H), 3.46 (d, J = 12.32 Hz, 1H), 3.29-3.13 (m, 1H), 
2.83 (t, J = 8.33 Hz, 1H), 2.45-2.33 (m, 1H), 2.26 (s, 3H), 1.56-1.50 (m, 1H), 1.31 (dd, J 
= 7.18, 4.78 Hz, 1H), 1.44 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ 173.7, 137.9, 135.9, 
129.9, 128.2, 127.8, 126.1, 81.5, 62.3, 32.3, 30.7, 28.1, 21.4, 17.4. HPLC analysis: ee = 
99%. AD-H (99% hexanes: 1% isopropanol, 0.8 ml/min) tmajor = 33.50 min, tminor = 21.76 
min. 
 
 
tert-butyl 2-(4-fluorophenyl)-1-formylcyclopropanecarboxylate(46e): 1H NMR (250 
MHz, CDCl3): δ 9.87 (s, 1H), 7.08-7.14 (m, 2H), 6.95-6.84 (m, 3H), 3.26 (t, J = 8.91 Hz, 
1H), 2.21 (dd, J = 8.68, 4.38 Hz, 1H), 1.91 (dd, J = 9.13, 4.34 Hz, 1H), 1.48 (s, 9H). 13C 
NMR (62.5 MHz, CDCl3): δ 195.5, 169.5, 164.1, 160.2, 131.3, 131.2, 128.8, 128.8, 115.2, 
114.9, 82.7, 42.0, 40.6, 28.2, 20.3. 
 
 
tert-butyl 2-(4-fluorophenyl)-1-(hydroxymethyl)cyclopropanecarboxylate(46ea): 1H 
NMR (250 MHz, CDCl3): δ7.16 (dd, J = 8.55, 5.76 Hz, 2H), 6.92 (t, J = 8.68 Hz, 2H), 
3.31 (s, 2H), 2.81 (m, 1H), 2.57-2.40 (br, 1H), 1.53 (dd, J = 8.97, 4.79 Hz, 1H), 1.44 (s, 
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10H), 1.21 (m, 1H). 13C NMR (62.5 MHz, CDCl3): δ 173.6, 163.8, 159.9, 131.8, 130.9, 
130.8, 129.2, 128.3, 115.4, 115.0, 81.7, 62.2, 32.2, 30.1, 28.1, 17.6. HPLC analysis: ee = 
97%. AD-H (99% hexanes: 1% isopropanol, 0.8 ml/min) tmajor = 25.90 min, tminor = 23.42 
min. 
 
 
tert-butyl 1-formyl-2-(4-(trifluoromethyl)phenyl)cyclopropanecarboxylate(46f): 1H 
NMR (250 MHz, CDCl3): δ 9.88 (s, 1H), 7.46 (d, J = 8.10 Hz, 2H), 7.25 (d, J = 8.31 Hz, 
2H), 3.30 (t, J = 8.88 Hz, 1H), 2.25 (dd, J = 8.65, 4.42 Hz, 1H), 1.94 (dd, J = 9.06, 4.34 
Hz, 1H), 1.49 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ 195.2, 169.2, 137.2, 130.5, 130.0, 
129.4, 128.9, 126.2, 125.8, 125.1, 125.0, 125.0, 124.9, 121.8, 82.9, 41.9, 40.1, 28.1, 27.6, 
20.2. 
 
 
tert-butyl 1-(hydroxymethyl)-2-(4-(trifluoromethyl)phenyl)cyclopropanecarboxylate 
(46fa): 1H NMR (600 MHz, CDCl3): δ 7.53 (d, J = 8.18 Hz, 2H), 7.37 (d, J = 8.06 Hz, 
2H), 3.41 (d, J = 12.47 Hz, 1H), 3.33 (d, J = 12.39 Hz, 1H), 2.93 (t, J = 8.00 Hz, 1H), 
2.52 (s, 1H), 1.63 (dd, J = 8.91, 4.92 Hz, 1H), 1.50 (s, 11H), 1.34 (dd, J = 7.13, 4.94 Hz, 
1H). 13C NMR (62.5 MHz, CDCl3): δ 172.2, 139.3, 128.6, 128.4, 127.9, 125.2, 124.3, 
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124.2, 124.1, 124.1, 120.9, 80.9, 60.9, 31.5, 29.3, 27.1, 16.3. HPLC analysis: ee = 96%. 
AD-H (99% hexanes: 1% isopropanol, 0.8 ml/min) tmajor = 21.08 min, tminor = 46.67 min. 
 
 
tert-butyl 1-formyl-2-(3-nitrophenyl)cyclopropanecarboxylate(46g): 1H NMR (250 
MHz, CDCl3): δ 9.93 (s, 1H), 8.08-7.98 (m, 2H), 7.54-7.32 (m, 2H), 3.35 (t, J = 8.89 Hz, 
1H), 2.27 (dd, J = 8.61, 4.45 Hz, 1H), 2.00 (dd, J = 9.13, 4.43 Hz, 1H), 1.51 (s, 9H). 13C 
NMR (62.5 MHz, CDCl3): δ 194.3, 167.9, 146.9, 134.6, 127.9, 123.8, 121.6, 82.1, 40.5, 
38.5, 27.1, 19.8. HPLC analysis: ee = 97%. Whelk (98% hexanes: 2% isopropanol, 0.8 
ml/min) tmajor = 29.74 min, tminor = 50.48 min. 
 
 
tert-butyl 2-(3-bromophenyl)-1-formylcyclopropanecarboxylate(46h): 1H NMR (250 
MHz, CDCl3): δ 9.87 (s, 1H), 7.29 (m, 2H), 7.07 (m, 2H), 3.23 (t, J = 8.85 Hz, 1H), 2.20 
(dd, J = 8.60, 4.38 Hz, 1H), 1.89 (dd, J = 9.13, 4.37 Hz, 1H), 1.49 (s, 9H). 13C NMR 
(62.5 MHz, CDCl3): δ 195.2, 169.3, 135.5, 132.8, 130.8, 129.6, 128.2, 122.2, 82.8, 41.8, 
40.1, 28.2, 20.1. HPLC analysis: ee = 99%. Whelk (98% hexanes: 2% isopropanol, 0.8 
ml/min) tmajor = 12.65 min, tminor = 27.37 min. 
117 
 
 
 
tert-butyl 2-(2-bromophenyl)-1-formylcyclopropanecarboxylate(46i): 1H NMR (250 
MHz, CDCl3): δ 10.01 (s, 1H), 7.43 (d, J = 7.87 Hz, 1H), 7.21 (m, 2H), 7.11-7.02 (m, 
1H), 3.12 (t, J = 8.79 Hz, 1H), 2.20 (dd, J = 8.71, 4.20 Hz, 1H), 1.97 (dd, J = 8.89, 4.24 
Hz, 1H), 1.50 (s, 9H). 13C NMR (62.5 MHz, CDCl3): δ 194.9, 169.5, 134.0, 132.1, 131.4, 
129.3, 127.1, 126.5, 82.5, 42.2, 40.7, 28.2, 20.9. HPLC analysis: ee = 98%. Whelk (99% 
hexanes: 1% isopropanol, 0.8 ml/min) tmajor = 15.50 min, tminor = 57.33 min. 
 
 
tert-butyl 1-formyl-2-methyl-2-phenylcyclopropanecarboxylate(46j): 1H NMR (250 
MHz, CDCl3): δ 9.44 (s, 1H), 7.33-7.08 (m, 5H), 2.18 (d, J = 4.96 Hz, 1H), 1.79 (d, J = 
4.96 Hz, 1H), 1.51 (s, 12H). 13C NMR (62.5 MHz, CDCl3): δ 196.1, 167.9, 140.0, 128.8, 
128.5, 127.3, 82.4, 48.0, 44.2, 28.3, 23.4, 23.3. HPLC analysis: ee = 94%. Whelk (98% 
hexanes: 2% isopropanol, 0.8 ml/min) tmajor = 11.58 min, tminor = 18.90 min. 
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tert-butyl 1-formyl-2-(naphthalen-2-yl)cyclopropanecarboxylate(46k): 1H NMR (250 
MHz, CDCl3): δ 9.86 (s, 1H), 7.79-7.14 (m, 7H), 3.45 (t, J = 8.91 Hz, 1H), 2.40 (dd, J = 
8.66, 4.36 Hz, 1H), 1.98 (dd, J = 9.04, 4.32 Hz, 1H), 1.50 (s, 9H). 13C NMR (62.5 MHz, 
CDCl3): δ 195.2, 169.6, 133.0, 132.7, 130.5, 128.6, 127.9, 127.7, 127.6, 127.5, 126.2, 
126.1, 82.6, 42.2, 41.5, 28.2, 20.0. 
 
 
tert-butyl 1-(hydroxymethyl)-2-(naphthalen-2-yl)cyclopropanecarboxylate(46ka): 1H 
NMR (250 MHz, CDCl3): δ 7.71 (d, J = 8.80 Hz, 3H), 7.59 (s, 1H), 7.47-7.31 (m, 3H), 
3.48-3.36 (m, 1H), 3.35-3.23 (m, 1H), 3.01 (t, J = 7.94 Hz, 1H), 2.4(br, 1H), 1.62 (dd, J = 
8.86, 4.85 Hz, 1H), 1.47 (m,10H). 13C NMR (62.5 MHz, CDCl3): δ 173.7, 133.7, 133.2, 
132.5, 127.9, 127.8, 127.6, 127.3, 126.9, 126.2, 125.8, 81.6, 62.2, 32.7, 31.1, 28.2, 17.5. 
HPLC analysis: ee = 95%. OD-H (97% hexanes: 3% isopropanol, 0.8 ml/min) tmajor = 
29.44 min, tminor = 18.00 min. 
 
 
1-tert-butyl 2-methyl 1-formylcyclopropane-1,2-dicarboxylate(46l): Major isomer: 1H 
NMR (250 MHz, CDCl3): δ 9.94 (s, 1H), 3.64 (s, 3H), 2.64 (dd, J = 8.94, 7.82 Hz, 1H), 
2.06-1.93 (m, 1H), 1.72-1.60 (m, 1H), 1.43 (s, 9H). Minor isomer: 1H NMR (250 MHz, 
CDCl3): δ1H NMR (250 MHz, Solvent) d ppm 9.96 (s, 1H), 3.65 (s, 3H), 2.51 (m, 1H), 
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2.06-1.93 (m, 1H), 1.72-1.60 (m, 1H), 1.44 (s, 9H), 13C NMR (62.5 MHz, CDCl3): δ 
196.3, 194.4, 168.1, 168.0, 167.7, 166.4, 83.4, 83.1, 52.5, 52.4, 40.7, 39.1, 32.7, 32.3, 
28.0, 27.9, 21.2, 20.4. GC analysis: ee (major) = 97 %. CP-Chirasil-Dex CB (Temp 
program: initial temp = 50° C, hold time = 5 min, Rate: 5.00° C/min, max temp =200° C, 
hold time= 5 min) tminor = 24.68 min, tmajor = 24.63 min. 
 
 
tert-butyl 2-ethyl 1-formylcyclopropane-1,2-dicarboxylate(46m): Major isomer: 1H 
NMR (250 MHz, CDCl3): δ  9.93 (s, 1H), 4.08 (m, 2H), 2.63 (t, J = 8.22 Hz, 1H), 2.07-
1.91 (m, 1H), 1.72-1.54 (m, 1H), 1.43 (s, 9H), 1.26-1.11 (m, 3H). Minor isomer: 1H NMR 
(250 MHz, CDCl3): δ  9.94 (s, 1H), 4.08 (m, 7H), 2.50 (t, J = 8.44 Hz, 1H), 2.07-1.91 (m, 
1H), 1.72-1.54 (m, 1H), 1.43 (s, 9H), 1.26-1.11 (m, 3H). 13C NMR (62.5 MHz, CDCl3): δ 
195.3, 193.3, 166.7, 166.6, 166.5, 165.3, 82.3, 82.0, 60.6, 60.5, 39.8, 38.1, 31.9, 31.5, 
27.0, 26.9, 20.1, 19.2, 13.1, 13.0. GC analysis: ee (major) = 96 %. CP-Chirasil-Dex CB 
(Temp program: initial temp = 50° C, hold time = 5 min, Rate: 5.00° C/min, max temp 
=200° C, hold time= 5 min): tminor = 25.80 min, tmajor = 25.74 min. 
 
 
ethyl 5-tert-butoxy-4,5-dihydrofuran-3-carboxylate(47a): 1H NMR (250 MHz, CDCl3): 
δ 7.27 (dd, J = 6.18, 4.07 Hz, 1H), 5.99 (dd, J = 7.70, 3.72 Hz, 1H), 4.19 (q, J = 7.11 Hz, 
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2H), 2.95 (dd, J = 7.73, 2.27 Hz, 1H), 2.80-2.57 (m, 1H), 1.27 (m, 12H). 13C NMR (62.5 
MHz, CDCl3): δ 165.0, 154.8, 108.0, 103.4, 76.0, 59.7, 35.5, 28.6, 14.4. HPLC analysis: 
ee = 25%. Whelk (98% hexanes: 2% isopropanol, 0.8 ml/min) tmajor = 13.58 min, tminor = 
11.50 min. 
 
 
ethyl 5-(4-methoxyphenyl)-4,5-dihydrofuran-3-carboxylate(47b): 1H NMR (250 MHz, 
CDCl3): δ 7.17-7.04 (m, 3H), 6.72 (d, J = 8.60 Hz, 2H), 5.57-5.43 (m, 1H), 4.01 (q, J = 
7.10 Hz, 2H), 3.63 (s, 3H), 3.06 (dd, J = 14.05, 11.25 Hz, 1H), 2.69 (dd, J = 14.62, 8.45 
Hz, 1H), 1.10 (t, J = 7.08 Hz, 3H).13C NMR (62.5 MHz, CDCl3): δ 159.7, 156.3, 133.0, 
127.4, 114.1, 108.8, 86.3, 59.9, 55.3, 35.8, 14.4. HPLC analysis: ee = 39%. OJ-H (97% 
hexanes: 3% isopropanol, 0.8 ml/min) tmajor = 64.81 min, tminor = 41.00 min. 
 
 
ethyl 5-p-tolyl-4,5-dihydrofuran-3-carboxylate(47c): 1H NMR (250 MHz, CDCl3): δ 
7.33 (t, J = 1.85 Hz, 1H), 7.25-7.14 (m, 4H), 5.70 (dd, J = 10.85, 8.59 Hz, 1H), 4.17 (q, J 
= 7.11 Hz, 2H), 3.25 (ddd, J = 14.85, 10.89, 1.88 Hz, 1H), 2.85 (ddd, J = 14.86, 8.57, 
1.84 Hz, 1H), 2.33 (s, 3H), 1.26 (t, J = 7.12 Hz, 3H). 13C NMR (62.5 MHz, CDCl3): δ 
165.1, 156.3, 138.2, 138.0, 129.4, 125.8, 108.7, 86.3, 59.8, 35.9, 21.1, 14.4, HPLC 
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analysis: ee = 99%. Whelk (% hexanes: % isopropanol, 0.8 ml/min) tmajor = 22.42 min, 
tminor = 20.52 min. 
4.5. Conclusions 
We have shown that the cyclopropyl carbaldehyde derivatives can be generated in 
excellent diastereo- and enantioselectivities through a broad range of terminal olefins 
utilizing [Co(P1)] as catalysts.  We have also shown the pathway to generate 
dihydrofuran through a tandem radical cyclization process, although yield is still low, 
further studies will be focused on developing the catalytic system that could tune the 
regioselectivity of dihydrofuran over cyclopropane, thus dihydrofuran could be generated 
with high yield and enantioselectivities. 
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Chapter 5 
Cobalt(II)-Catalyzed Enantioselective Intermolecular Cyclopropanation with 
Diazomalonates. 
5.1. Introduction 
The utility of cyclopropanes as building blocks for total organic synthesis 
compels the development of facile methods for their preparation,1 transition metal-
catalyzed carbene addition to olefins is one of the most developed methods to date.2 Due 
to their synthetic ease and relative stability, α-diazocarbonyls are widely used as carbene 
precursor for catalytic cyclopropanation reactions. It has become increasingly apparent 
that the reactivity profile of diazo reagents is very dependent on the nature of their α-
substituents. According to the electronic properties of the α-substituents, diazo reagents 
are classified into three major classes: acceptor, donor/acceptor, and acceptor/acceptor 
(Figure 5.1). With only one electron-withdrawing group, acceptor- and donor/acceptor-
substituted diazo reagents have relatively strong basicity. Correspondingly, 
acceptor/acceptor diazo reagents show the weakest base feature due to the presence of 
two electron-withdrawing groups and a highly delocalized negative charge. The 
reactivities of diazo compounds toward Lewis acids in diazo decomposition reactions 
generally depend on the basicity of the diazo compounds and are in a descending order 
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when the number of the acceptor groups increases.3 Acceptor- and donor/acceptor-
substituted diazo reagents have been well known to asymmetrically cyclopropanate 
olefins by Rh2- and Cu-based chiral catalysts. While these Lewis acidic metal catalysts 
show excellent reactivity and selectivity toward acceptor and donor/acceptor diazo 
reagents, the least basic acceptor/acceptor diazo reagents generally have much lower 
reactivity in Rh2- or Cu-based catalytic systems.2 Moreover, among several types of 
acceptor/acceptor diazo reagents, diazomalonates V (Figure 5.1) participated asymmetric 
cyclopropanation are the most challenging due to the following reasons: i) ester groups 
have more electron-deficiency than other carbonyl groups, leading to the lowest reactivity 
toward Rh2 or Cu catalysts; ii) the acceptor/acceptor metal carbene is correspondingly 
highly electrophilic, potentially undergoing addition reactions to olefins in low 
stereoselectivity; 3) In the case of diazomalonates with two different ester groups, the 
catalytic system must be able to distinguish between the two esters, which are much less 
differentiable than other combinations such as acetyl and ester groups. Due to the 
aforesaid reasons, although the corresponding electrophilic cyclopropanes are 
synthetically useful,4 enantioselective cyclopropanation reactions with diazomalonates 
are relatively less developed.5,6  
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Figure 5.1. Common Classification of Diazo Reagents and Their Reactivities toward 
Lewis Acidic Metal Catalysts. 
 
In contrast to the catalytic inefficiency of known Lewis acidic metal catalysts, the 
Co(II) complexes of porphyrins, a stable metalloradical with a well-defined open-shell 
doublet d7 electronic structure, have been demonstrated to be highly catalytic active for 
asymmetric cyclopropanation reactions with acceptor/acceptor diazo reagents.7 Co(II)-
based metalloradical cyclopropanation possesses a distinct reactivity profile due to its 
radical mechanism. Its catalytic cycle involves an unusual Co(III)-carbene radical as the 
key intermediate that  undergoes an unprecedented stepwise radical addition-substitution 
pathway.8 It is evident that the non-electrophilic radical-type catalytic system has less 
dependence on the electronic properties of α-substituents, leading to the exceptional 
efficiency toward several types of acceptor/acceptor diazo reagents, including α-
nitrodiazoacetates7a, α-cyanodiazoacetates7b, α-ketodiazoacetates7c and α-
formyldiazoacetates.7c Thus, diazomalonates may also be as active as other 
acceptor/acceptor diazo reagents toward Co(II)-based metalloradical catalysis, despite it 
showed the least reactivity in Rh2- or Cu-based catalysis. Moreover, the potential double 
hydrogen bonding interaction between diazomalonates and the amidoporphyrin ligand 
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may further stabilize and rigidify the intermediates and promote the stereoselectivities 
(Figure 5.2).7b After a successful intramolecular version of Co(II)-catalyzed 
cyclopropanation with diazomalonates was developed,9 we decided to explore a more 
general intermolecular catalytic system with this type of challenging diazo reagents, 
accessing broadly useful cyclopropane-1,1-dicarboxylates.10  
 
 
Figure 5.2. Structures of D2-symmetric chiral cobalt(II) porphyrins. 
 
In our previous reports we demonstrated that [Co(P1)], the cobalt(II) complex of 
the D2-symmetric chiral porphyrin 3,5-DitBu-ChenPhyrin (Figure 5.2) is a highly 
effective catalyst for asymmetric olefin cyclopropanation with α-nitrodiazoacetates7a and 
α-cyanodiazoacetates7b. We rationalized that the general success in stereoselectivities 
may be attributed to the rigidity of the cyclopropyl group in ligand P1 and the potential 
double hydrogen bonding. Start from [Co(P1)], we investigated the catalytic 
cyclopropanation reactions of styrene with a variety of diazomalonates. 
 
5.2. Results and Discussion 
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Table 5.1. Cyclopropanation with Diazomalonates Catalyzed by [Co(P1)]. a 
 
a Reaction conditions: Performed for 24 h in one-time fashion without slow addition of 
the diazo reagent under N2 with 1.2 equiv of diazo reagent and 1.0 equiv of alkene. 
[substrate] = 0.2 M. b Isolated yield. c ee determined by chiral HPLC. 
 
As shown in Table 5.1, dimethyl diazomalonate reacted smoothly with a 
stoichiometric amount of styrene, yielding the desired product in quantitative yield but 
with low enantioselectivity (Table 5.1, entry 1). When diethyl diazomalonate was used, 
the enantioselectivity of the reaction almost doubled albeit a decreased product yield 
(Table 5.1, entries 2). A 5 mol % catalyst loading compensated the loss of reactivity 
(Table 5.1, entry 3). The use of sterically more hindered diisopropyl diazomalonate led to 
lower yield without further improvement of enantioselectivity (Table 5.1, entry 4). For 
improving the enantioselectivity of this reaction, we attempted to increase the enantioface 
differentiation of the metal-carbene moiety by using unsymmetric 1-tert-butyl 3-methyl 
2-diazomalonate. As shown in entry 5, the enantiomeric excess increased to 74% 
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although the reaction yield was low. Of the solvents tested, toluene turned out to be 
optimal with respect to balancing high enantiomeric excess, diastereomeric ratio and 
satisfying yield (Table 5.1, entries 5-8). 
With the optimal diazo reagent and conditions, we attempted to tune the chiral 
environment of the porphyrin ligand. Cobalt(II) complex of 3,5-DitBu-QingPhyrin (P7) 
(Figure 5.3), sharing a similar but more hindered chiral environment with [Co(P1)], was 
previously shown to be suitable for symmetric intramolecular cyclopropanation with 
diazomalonates.9 Therefore we tested [Co(P7)] for this intermolecular cyclopropanation 
system. It was shown that [Co(P7)] could catalyze the reactions with generally higher 
enantioselectivity (Table 5.2, entries 1-4), albeit with slower reaction rates. For example, 
1-tert-butyl 3-methyl 2-diazomalonate was converted into the expected product in only 
14% yield but with an impressive enantiomeric excess of 99% at room temperature for 24 
h (Table 5.2, entry 4). Gratifyingly, the reaction yields were improved by increasing the 
reaction temperature to 40 °C and extending the reaction time to 80 h (Table 5.2, entry 6) 
without sacrificing enantiomeric excess. It was noted that the enantioselectivity of this 
reaction is not substantially affected by substituents on styrene (Table 5.2, entries 7-9), 
whereas the yield varied considerably.  
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Figure 5.3. Structures of [Co(P1)] and [Co(P7)]. 
 
 
Table 5.2. Cyclopropanation with Diazomalonates Catalyzed by [Co(P7)]. a 
a Reaction conditions: Performed for 24 h in one-time fashion without slow addition of 
the diazo reagent under N2 with 1.2 equiv of diazo reagent and 1.0 equiv of alkene. 
[substrate] = 0.2 M. b Isolated yied. c ee determined by chiral HPLC. 
 
5.3. Experimental Section 
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General Considerations. All cyclopropanation reactions were carried out under a 
nitrogen atmosphere in oven-dried glassware following standard Schlenk techniques. 
Toluene was distilled under nitrogen from sodium benzophenone ketyl. Thin layer 
chromatography was performed on Merck TLC plates (silica gel 60 F254). Flash column 
chromatography was performed with ICN silica gel (60 Å, 230-400 mesh, 32-63 μm). 
Proton and carbon nuclear magnetic resonance spectra (1H NMR and 13C NMR) were 
recorded on a Bruker250 (250 MHz) or Varian Inova400 (400 MHz) or UnityInova 600 
(600 MHz) instrument with chemical shifts reported relative to residual solvent. HPLC 
measurements were carried out on a Shimadzu HPLC system with Whelk-O1,Chiralcel 
OD-H, OJ-H, and AD-H columns. HRMS data was obtained on an Agilent 1100 LC/MS 
ESI/TOF mass spectrometer with electrospray ionization.  
Preparation of the diazomalonates:  
Dimethyl diazomalonate (48a),11 Diethyl diazomalonate (48b),12 Diisopropyl 
diazomalonate (48c) and 1-tert-butyl 3-methyl 2-diazomalonate (48d) were synthesized 
according to reported procedure.13  
 
 
diisopropyl 2-diazomalonate(48c): 1H NMR (250 MHz, CDCl3):  5.13 (m, 2H), 1.27 (d, 
J = 6.29 Hz, 12H). 13C NMR (62.5 MHz, CDCl3): δ 159.7, 68.6, 64.6, 21.3. 
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1-tert-butyl 3-methyl 2-diazomalonate(48d): 1H NMR (250 MHz, CDCl3): δ 3.745 (s, 
3H), 1.443 (S, 9H). 13C NMR (62.5 MHz, CDCl3): δ 160.8, 158.9, 82.1, 64.7, 51.5, 21.5. 
 
General Procedure for Cyclopropanation: Catalyst (5 mol %) was placed in an 
oven-dried, resealable Schlenk tube. The tube was capped with a Teflon screwcap, 
evacuated, and backfilled with nitrogen. The screwcap was replaced with a rubber septum. 
1.0 Equivalents of alkene (0.10 mmol), 1.2 equivalents of diazo compound (0.12 mmol) 
in 0.5 ml toluene was added once via syringe. Schlenk tube was capped by teflon 
screwcap instead of rubber septum and stirred at room temperature. Following 
completion of the reaction, the reaction mixture was purified by flash chromatography. 
The fractions containing product were collected and concentrated by rotary evaporation 
to afford the compound. In most cases, the product was visualized on TLC using the 
cerium ammonium molybdate (CAM) stain. 
 
CO2Me
CO2tBu
 
1-tert-butyl 1-methyl 2-phenylcyclopropane-1,1-dicarboxylate(49d): 
1H NMR of major diastereomer (250 MHz, CDCl3): δ  7.14 (m, 5H), 3.30 (s, 3H), 3.10-
3.00 (m, 1H), 2.02 (dd, J = 7.91, 5.12 Hz, 1H), 1.58 (dd, J = 9.20, 5.12 Hz, 2H), 1.41 (s, 
9H).13C NMR of major diastereomer (62.5 MHz, CDCl3): δ 168.6, 167.7, 135.0, 128.3, 
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128.1, 127.2, 82.0, 52.0, 38.5, 31.6, 28.0, 18.6. HPLC analysis: ee (major)= 95%. OJ-H 
(99% hexanes:1% isopropanol, 0.8 ml/min) tmajor = 10.55 min, tminor = 9.04 min. 
 
 
1-tert-butyl 1-methyl 2-p-tolylcyclopropane-1,1-dicarboxylate(50): 1H NMR of major 
diastereomer (250 MHz, CDCl3): δ 6.99 (s, 4H), 3.33 (s, 3H), 3.07-2.96 (m, 1H), 2.23 (s, 
3H), 1.99 (dd, J = 7.92, 5.05 Hz, 1H), 1.55 (dd, J = 9.22, 5.04 Hz, 1H), 1.41 (s, 9H). 13C 
NMR (62.5 MHz, CDCl3) of two diastereomers: δ 170.9, 168.7, 167.7, 165.5, 136.8, 
136.8, 131.9, 131.6, 128.8, 128.8, 128.7, 128.2, 81.9, 81.2, 52.5, 52.0, 38.4, 38.0, 31.8, 
31.4, 28.0, 27.4, 21.1, 21.0, 18.7, 18.4. HPLC analysis: ee (major)= 96%. Whelk (99% 
hexanes:1% isopropanol, 0.8 ml/min) tmajor = 11.43 min, tminor = 10.32 min. 
 
 
1-tert-butyl 1-methyl 2-(4-(trifluoromethyl)phenyl)cyclopropane-1,1-dicarboxylate 
(51): 1H NMR of major diastereomer (250 MHz, CDCl3): δ  7.45 (d, J = 8.17 Hz, 2H), 
7.23 (d, J = 8.14 Hz, 2H), 3.33 (s, 3H), 3.08 (t, J = 8.42 Hz, 1H), 2.03 (dd, J = 7.87, 5.27 
Hz, 1H), 1.62 (dd, J = 9.14, 5.27 Hz, 1H), 1.42 (s, 9H). 13C NMR of two diastereomers 
(62.5 MHz, CDCl3): δ 170.4, 168.2, 167.2, 165.1, 139.3, 139.1, 129.2, 128.7, 126.2, 
125.1, 125.1, 125.0, 125.0, 121.9, 82.4, 81.8, 52.7, 52.2, 38.7, 38.3, 31.2, 30.9, 28.0, 27.3, 
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18.6, 18.3. HPLC analysis: ee (major)= 99%. Whelk (100% hexanes:0% isopropanol, 0.8 
ml/min) tmajor = 24.69 min, tminor = 22.64 min. 
 
 
1-tert-butyl 1-methyl 2-m-tolylcyclopropane-1,1-dicarboxylate(52): 1H NMR (250 
MHz, CDCl3) of major diastereomer: δ  7.12-6.84 (m, 4H), 3.32 (s, 3H), 3.01 (t, J = 8.54 
Hz, 1H), 2.23 (s, 3H), 1.99 (dd, J = 7.89, 5.09 Hz, 1H), 1.56 (dd, J = 9.22, 5.06 Hz, 1H), 
1.41 (s, 9H). 13C NMR of two diastereomers (62.5 MHz, CDCl3): δ  170.9, 168.7, 167.6, 
165.5, 137.7, 137.5, 135.1, 135.0, 134.7, 134.5, 129.5, 129.2, 128.4, 128.0, 125.9, 125.1, 
82.0, 81.2, 52.6, 52.0, 38.4, 37.9, 32.0, 31.6, 28.0, 27.4, 21.3, 21.3, 18.7, 18.4. HPLC 
analysis: ee (major)= 98%. Whelk (99% hexanes:1% isopropanol, 0.8 ml/min) tmajor = 
10.84 min, tminor = 9.88 min. 
 
5.4. Conclusions 
We have demonstrated that metalloradical catalyst [Co(P7)] is an efficient 
catalyst for highly diastereo- and enantioselective cyclopropanation of alkenes with 
diazomalonates. The resulting chiral cyclopropane derivatives bearing two geminal ester 
groups possess a myriad of potential synthetic applications. While being challenging in 
Rh2- and Cu-based catalytic systems, the high reactivity and selectivity shown by 
employing diazomalonates in this work is believed to have close relevance to the radical 
pathway of Co(II)-based metalloradical catalysis. Furthermore, the establishment of 
diazomalonates as effective and selective carbene sources for cyclopropanation may 
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encourage further development of new catalytic systems for the wide use of this and other 
acceptor/acceptor-substituted diazo reagents for various stereoselective carbene transfer 
processes.  
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6.1. Spectral Data for Chapter 2 
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6.2. Spectral Data for Chapter 3 
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6.3. Spectral Data for Chapter 4 
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6.4. Spectral Data for Chapter 5 
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